was read the article
array:23 [ "pii" => "S1665268121002568" "issn" => "16652681" "doi" => "10.1016/j.aohep.2021.100557" "estado" => "S300" "fechaPublicacion" => "2021-12-01" "aid" => "100557" "copyrightAnyo" => "2021" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "Ann Hepatol. 2021;26C:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:19 [ "pii" => "S1665268121002465" "issn" => "16652681" "doi" => "10.1016/j.aohep.2021.100547" "estado" => "S300" "fechaPublicacion" => "2021-12-01" "aid" => "100547" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "Ann Hepatol. 2021;26C:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Concise review</span>" "titulo" => "Safety and efficacy of human serum albumin treatment in patients with cirrhotic ascites undergoing paracentesis: A systematic review and meta-analysis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0006" "etiqueta" => "Fig. 6" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr6.jpeg" "Alto" => 1836 "Ancho" => 3583 "Tamanyo" => 564164 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0006" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spara006" class="elsevierStyleSimplePara elsevierViewall">Forest plot showing hospital readmission comparing albumin with other therapy using fixed effect model.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Dhan Bahadur Shrestha, Pravash Budhathoki, Yub Raj Sedhai, Ramkaji Baniya, Shila Awal, Jashpal Yadav, Lila Awal, Brian Davis, Markos G. Kashiouris, Casey A. Cable" "autores" => array:10 [ 0 => array:2 [ "nombre" => "Dhan Bahadur" "apellidos" => "Shrestha" ] 1 => array:2 [ "nombre" => "Pravash" "apellidos" => "Budhathoki" ] 2 => array:2 [ "nombre" => "Yub Raj" "apellidos" => "Sedhai" ] 3 => array:2 [ "nombre" => "Ramkaji" "apellidos" => "Baniya" ] 4 => array:2 [ "nombre" => "Shila" "apellidos" => "Awal" ] 5 => array:2 [ "nombre" => "Jashpal" "apellidos" => "Yadav" ] 6 => array:2 [ "nombre" => "Lila" "apellidos" => "Awal" ] 7 => array:2 [ "nombre" => "Brian" "apellidos" => "Davis" ] 8 => array:2 [ "nombre" => "Markos G." "apellidos" => "Kashiouris" ] 9 => array:2 [ "nombre" => "Casey A." "apellidos" => "Cable" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268121002465?idApp=UINPBA00004N" "url" => "/16652681/000000260000000C/v5_202208200714/S1665268121002465/v5_202208200714/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1665268121002295" "issn" => "16652681" "doi" => "10.1016/j.aohep.2021.100530" "estado" => "S300" "fechaPublicacion" => "2021-12-01" "aid" => "100530" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "rev" "cita" => "Ann Hepatol. 2021;26C:" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Concise review</span>" "titulo" => "Mechanism of cholangiocellular damage and repair during cholestasis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0003" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 2040 "Ancho" => 2749 "Tamanyo" => 556022 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0003" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spara003" class="elsevierStyleSimplePara elsevierViewall">Liver changes induced by chemical cholestasis. Damage induced by α-naphthylisothiocyanate (ANIT), and bile duct ligation (BDL) generate changes in the size and color of the gallbladder (asterisk), inflammation of the common bile duct (star) and necrotic lesions (arrows).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Soraya Salas-Silva, Arturo Simoni-Nieves, Lisette Chávez-Rodríguez, María Concepción Gutiérrez-Ruiz, Leticia Bucio, Luis E. Gomez Quiroz" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Soraya" "apellidos" => "Salas-Silva" ] 1 => array:2 [ "nombre" => "Arturo" "apellidos" => "Simoni-Nieves" ] 2 => array:2 [ "nombre" => "Lisette" "apellidos" => "Chávez-Rodríguez" ] 3 => array:2 [ "nombre" => "María Concepción" "apellidos" => "Gutiérrez-Ruiz" ] 4 => array:2 [ "nombre" => "Leticia" "apellidos" => "Bucio" ] 5 => array:2 [ "nombre" => "Luis E. Gomez" "apellidos" => "Quiroz" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268121002295?idApp=UINPBA00004N" "url" => "/16652681/000000260000000C/v5_202208200714/S1665268121002295/v5_202208200714/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Concise reviews</span>" "titulo" => "Pregnancy in Chronic Liver Disease: Before and After Transplantation" "tieneTextoCompleto" => true "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Amr Dokmak, Hirsh D. Trivedi, Alan Bonder, Jacqueline Wolf" "autores" => array:4 [ 0 => array:4 [ "nombre" => "Amr" "apellidos" => "Dokmak" "email" => array:1 [ 0 => "amr.dokmak@cmc-nh.org" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0001" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0001" ] ] ] 1 => array:3 [ "nombre" => "Hirsh D." "apellidos" => "Trivedi" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0002" ] ] ] 2 => array:3 [ "nombre" => "Alan" "apellidos" => "Bonder" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0003" ] ] ] 3 => array:3 [ "nombre" => "Jacqueline" "apellidos" => "Wolf" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0002" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Department of Hospital Medicine, Catholic Medical Center, Manchester, NH, USA" "etiqueta" => "a" "identificador" => "aff0001" ] 1 => array:3 [ "entidad" => "Department of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA" "etiqueta" => "b" "identificador" => "aff0002" ] 2 => array:3 [ "entidad" => "Liver Center, Department of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA" "etiqueta" => "c" "identificador" => "aff0003" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0001" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0001" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">1</span><span class="elsevierStyleSectionTitle" id="cesectitle0003">Introduction</span><p id="para0001" class="elsevierStylePara elsevierViewall">The prevalence of chronic liver disease among women of young age (15–39 years) has increased from 10.4% in 1994 to 24.9% in 2012 (<span class="elsevierStyleItalic">p</span><0.001). <a class="elsevierStyleCrossRef" href="#bib0001">[1]</a> The 2010 United States(US) Census data estimated the number of women with cirrhosis to be 172,897. <a class="elsevierStyleCrossRef" href="#bib0002">[2]</a> Chronic liver disease and liver transplantation (LT) directly impact pregnancy-related outcomes. Cirrhosis, with or without portal hypertension, is associated with increased maternal and fetal complications. <a class="elsevierStyleCrossRef" href="#bib0003">[3]</a> Due to the rising prevalence of chronic liver disease among young women and the direct effect it has on pregnancy-related outcomes, awareness of pregnancy-specific disease features and tailored management are important to optimize maternal and fetal outcomes.</p><p id="para0002" class="elsevierStylePara elsevierViewall">In this review, we discuss the impact of chronic liver disease in women of reproductive age and emphasize management considerations in pregnancy. We highlight the disease-specific implications of pregnancy and summarize post-LT care in women of childbearing potential.</p></span><span id="sec0002" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">2</span><span class="elsevierStyleSectionTitle" id="cesectitle0004">Search strategy</span><p id="para0003" class="elsevierStylePara elsevierViewall">A comprehensive literature search was performed using keywords and index terms in the MEDLINE database. The search was designed to yield potential reports pertaining to the management of chronic liver disease in pregnancy between January 1, 1971 and March 1, 2021. Keywords and index terms for “chronic liver disease”, “cirrhosis”, “pregnancy”, and “liver transplant”, in addition to term variations, without language or study design restrictions were employed. Reference lists of included studies were screened for additional eligible articles that were found to be relevant to the creation of this narrative review article.</p></span><span id="sec0003" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3</span><span class="elsevierStyleSectionTitle" id="cesectitle0005">General considerations</span><span id="sec0004" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3.1</span><span class="elsevierStyleSectionTitle" id="cesectitle0006">Impact on fertility</span><p id="para0004" class="elsevierStylePara elsevierViewall">Pregnancy in women with cirrhosis is uncommon, partly due to cirrhosis-induced infertility. 30–71% of women with cirrhosis experience amenorrhea. [<a class="elsevierStyleCrossRef" href="#bib0004">4</a>,<a class="elsevierStyleCrossRef" href="#bib0005">5</a>] Cirrhosis is present in approximately 1 in 3333 pregnancies. <a class="elsevierStyleCrossRef" href="#bib0006">[6]</a> Infertility is proposed to occur due to hypothalamic-pituitary axis dysfunction and abnormal hepatic sex hormone metabolism leading to anovulation and amenorrhea. [<a class="elsevierStyleCrossRef" href="#bib0007">7</a>,<a class="elsevierStyleCrossRef" href="#bib0008">8</a>] Optimizing synthetic function and maintaining liver health are key measures to enhancing fertility.</p></span><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3.2</span><span class="elsevierStyleSectionTitle" id="cesectitle0007">Maternal complications</span><p id="para0005" class="elsevierStylePara elsevierViewall">Pregnancy-related complications in cirrhosis are observed at a higher rate compared to the general population. Reports from the US Nationwide Inpatient Sample (NIS) database reveal an increased maternal complication rate (Odds Ratio [OR]2.03; 95% Confidence Interval [CI] 1.60–2.57) in women with cirrhosis as well as a 6% mortality rate in those with decompensated disease. <a class="elsevierStyleCrossRef" href="#bib0003">[3]</a> A study including 339 obstetric hospitalizations in the US between 1993 and 2005 revealed a higher likelihood of antepartum hospitalization (OR 2.97; 95%CI 2.24–3.96) and Caesarean-section (C-section) deliveries (42%vs28%; adjusted OR [aOR]1.41; 95%CI 1.06–1.88) in pregnant women with cirrhosis though specific C-section indications were not reported. <a class="elsevierStyleCrossRef" href="#bib0003">[3]</a> Gestational complications were increased in cirrhosis and included placental abruption (7.1%vs1.7%; <span class="elsevierStyleItalic">p</span><0.0001,95%CI 2.55–7.60), postpartum uterovaginal bleeding (13.3% vs 3.0%; <span class="elsevierStyleItalic">p</span><0.0001,95%CI 3.10–7.91), hypertension (14.5%vs9.4%; <span class="elsevierStyleItalic">p</span> = 0.003 95%CI 1.19–2.23), and need for blood transfusion (9.7%vs0.8%; <span class="elsevierStyleItalic">p</span><0.0001, 95%CI 8.68–21.40). <a class="elsevierStyleCrossRef" href="#bib0003">[3]</a> Further studies revealed a higher likelihood of maternal venous thromboembolism (aOR12.3; 95%CI 4.9–31), protein-calorie malnutrition (aOR67.4; 95%CI 11.9 – 29.0), and peripartum infection (aOR3.9; 95%CI 1.2–12.0) in cirrhosis. <a class="elsevierStyleCrossRef" href="#bib0009">[9]</a> Comparisons between decompensated and compensated cirrhosis revealed a higher rate of C-section delivery (72%vs47.6%; <span class="elsevierStyleItalic">p</span> = 0.04), preterm delivery (66%vs34.4%; <span class="elsevierStyleItalic">p</span> = 0.004), placenta previa (4.6%vs0%; <span class="elsevierStyleItalic">p</span> = 0.005), and need for blood transfusion (40.9%vs9.3%; <span class="elsevierStyleItalic">p</span><0.001) in decompensated disease. <a class="elsevierStyleCrossRef" href="#bib0009">[9]</a></p><p id="para0006" class="elsevierStylePara elsevierViewall">Hepatic decompensation in pregnancy, observed in 15% of pregnant women with cirrhosis, can cause ascites and catastrophic bleeding from esophageal varices or splenic artery aneurysmal rupture. <a class="elsevierStyleCrossRef" href="#bib0003">[3]</a> Increase in plasma volume worsens portal hypertension. Historical data reports esophageal variceal bleeding in up to a third of pregnant women with cirrhosis and half of those with portal hypertension. [<a class="elsevierStyleCrossRef" href="#bib0010">10</a>,<a class="elsevierStyleCrossRef" href="#bib0011">11</a>] More recent data demonstrate lower variceal bleeding rates at approximately 5%. <a class="elsevierStyleCrossRef" href="#bib0003">[3]</a> Variceal bleeding is associated with an elevated risk of abortion (29.4%vs15.2%; <span class="elsevierStyleItalic">p</span>>0.05) and perinatal death (33.3%vs14.3%; <span class="elsevierStyleItalic">p</span>>0.05). <a class="elsevierStyleCrossRef" href="#bib0012">[12]</a></p><p id="para0007" class="elsevierStylePara elsevierViewall">Measures to decrease hepatic decompensation in pregnancy are crucial. Experts recommend a screening endoscopy during the second trimester given the increased circulating blood volume and fetal compression on the inferior vena cava. <a class="elsevierStyleCrossRef" href="#bib0013">[13]</a> Prophylaxis and treatment of bleeding from varices are similar to that in non-pregnant cirrhotics. Nonselective beta blockers can be used although carry a risk of neonatal bradycardia, hypoglycemia, and intrauterine growth retardation (<a class="elsevierStyleCrossRef" href="#tbl0001">Table 1</a>). The management of variceal bleeding requires endoscopic band ligation. Transjugular intrahepatic portosystemic shunt, which carries a low fetal radiation exposure risk, has been described as salvage therapy. <a class="elsevierStyleCrossRef" href="#bib0014">[14]</a></p><elsevierMultimedia ident="tbl0001"></elsevierMultimedia></span><span id="sec0006" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3.3</span><span class="elsevierStyleSectionTitle" id="cesectitle0008">Fetal complications</span><p id="para0008" class="elsevierStylePara elsevierViewall">Fetal complications are also higher with liver disease. An NIS database study reveals an increased fetal complication rate (OR3.66; 95%CI 2.74–4.88) and 12% fetal mortality rate in cases of decompensated maternal disease. <a class="elsevierStyleCrossRef" href="#bib0003">[3]</a> Cirrhosis is associated with higher rates of preterm birth (38.7% vs 10.3%; CI 4.16%−7.30%, <span class="elsevierStyleItalic">p</span><0.0001) and fetal intrauterine growth restriction (5.3% vs 2.1%; CI 1.47%−4.96%, <span class="elsevierStyleItalic">p</span> = 0.003). <a class="elsevierStyleCrossRef" href="#bib0003">[3]</a> Adequate management of underlying liver pathology and maintenance of hepatic function are essential for a safe and successful pregnancy.</p></span><span id="sec0007" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3.4</span><span class="elsevierStyleSectionTitle" id="cesectitle0009">Mode of delivery</span><p id="para0009" class="elsevierStylePara elsevierViewall">The optimal mode of delivery in women with portal hypertension remains controversial as there are no large randomized studies. Prolonged vaginal deliveries involving augmented intra-abdominal pressures through repetitive Valsalva maneuvers increase portal pressure, but the effect on variceal bleeding remains unclear. [<a class="elsevierStyleCrossRef" href="#bib0013">13</a>,<a class="elsevierStyleCrossRef" href="#bib0015">15</a>] In women with portal hypertension, C-section delivery may carry a higher risk of hemorrhage via portal hypertensive collaterals. <a class="elsevierStyleCrossRef" href="#bib0013">[13]</a> A shortened second stage of delivery, through forceps use, in conjunction with extradural anesthesia has been done. <a class="elsevierStyleCrossRef" href="#bib0016">[16]</a> If a C-section delivery is planned for a woman with cirrhosis, adequate vascular surgery support is prudent. <a class="elsevierStyleCrossRef" href="#bib0017">[17]</a></p></span><span id="sec0008" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">3.5</span><span class="elsevierStyleSectionTitle" id="cesectitle0010">Prognostication</span><p id="para0010" class="elsevierStylePara elsevierViewall">It is important for providers to educate cirrhotic patients about risks. Model for end-stage liver disease (MELD) can be used in predicting pregnancy outcomes. <a class="elsevierStyleCrossRef" href="#bib0018">[18]</a> MELD scores above 10 (83% sensitivity, 83% specificity) strongly correlate with gestational hepatic decompensation. <a class="elsevierStyleCrossRef" href="#bib0018">[18]</a></p></span></span><span id="sec0009" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">4</span><span class="elsevierStyleSectionTitle" id="cesectitle0011">Disease-Specific implications to pregnancy: Hepatitis B virus (HBV)</span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">4.1</span><span class="elsevierStyleSectionTitle" id="cesectitle0012">Maternal and fetal complications</span><p id="para0011" class="elsevierStylePara elsevierViewall">The worldwide prevalence of chronic HBV is estimated to be 250 million, a quarter of which are estimated to be women of reproductive age who can theoretically transmit the virus to their offspring. <a class="elsevierStyleCrossRef" href="#bib0019">[19]</a> Historical studies do not reveal a significant association between maternal HBV and adverse pregnancy outcomes. [<a class="elsevierStyleCrossRef" href="#bib0020">20</a>,<a class="elsevierStyleCrossRef" href="#bib0021">21</a>] More recent data, however, demonstrate the significant impact maternal HBV imposes on pregnancy. Hepatitis B surface antigen (HBsAg)-positive status is, in fact, associated with increased rates of gestational diabetes mellitus (GDM) (OR2.04; 95%CI 1.21–3.44, <span class="elsevierStyleItalic">p</span> = 0.008) (<a class="elsevierStyleCrossRef" href="#tbl0002">Table 2</a>), antepartum hemorrhage(OR2.18; 95%CI 1.11–4.26, <span class="elsevierStyleItalic">p</span> = 0.023), and threatened preterm labor(OR2.007; 95%CI 1.01–3.97, <span class="elsevierStyleItalic">p</span> = 0.046). <a class="elsevierStyleCrossRef" href="#bib0022">[22]</a> There is no increased incidence of preterm labor, preeclampsia, placenta previa, placental abruption, preterm premature rupture of membranes, or birth weight. <a class="elsevierStyleCrossRef" href="#bib0022">[22]</a></p><elsevierMultimedia ident="tbl0002"></elsevierMultimedia><p id="para0012" class="elsevierStylePara elsevierViewall">Another challenge is that up to 44% of women with HBV experience a disease flare within 1 month of delivery. <a class="elsevierStyleCrossRef" href="#bib0023">[23]</a> Higher rates of flares occur in untreated mothers with increased viremia or positive hepatitis B e antigen(HBeAg). <a class="elsevierStyleCrossRef" href="#bib0024">[24]</a> Most flares are self-limited though there have been reported cases of acute liver failure. <a class="elsevierStyleCrossRef" href="#bib0025">[25]</a></p></span><span id="sec0011" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">4.2</span><span class="elsevierStyleSectionTitle" id="cesectitle0013">Mother-to-Child transmission</span><p id="para0013" class="elsevierStylePara elsevierViewall">In an attempt to decrease mother-to-child transmission, all women contemplating pregnancy or pregnant should be screened for HBsAg. <a class="elsevierStyleCrossRef" href="#bib0026">[26]</a> HBV transmission can occur during gestation, delivery, and breastfeeding with maternal viremia and positive HBeAg status acting as key transmission contributors with rates nearing 90% in untreated HBeAg positive mothers. <a class="elsevierStyleCrossRefs" href="#bib0027">[27–30]</a> Early infection in life portends an increased risk of chronic infection with rates up to 95% in perinatally acquired infections as compared to 5–10% in adulthood acquired infections. <a class="elsevierStyleCrossRef" href="#bib0031">[31]</a></p></span><span id="sec0012" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">4.3</span><span class="elsevierStyleSectionTitle" id="cesectitle0014">Management of HBV in pregnancy</span><p id="para0014" class="elsevierStylePara elsevierViewall">American association for the study of liver diseases(AASLD) guidelines recommend timely antiviral therapy for all women who meet standard HBV treatment criteria. <a class="elsevierStyleCrossRef" href="#bib0026">[26]</a> Women who do not meet treatment criteria but carry HBV DNA levels greater than 200,000 IU/mL should be considered for treatment during the second trimester. <a class="elsevierStyleCrossRef" href="#bib0027">[27]</a> Women with cirrhosis should be started on tenofovir disoproxil fumarate(TDF) to prevent hepatic decompensation. <a class="elsevierStyleCrossRef" href="#bib0027">[27]</a> Entecavir has not been sufficiently studied in pregnant women with HBV and is not currently recommended. <a class="elsevierStyleCrossRef" href="#bib0027">[27]</a> TDF is the preferred agent of choice due to increased potency and lower resistance rates(<a class="elsevierStyleCrossRef" href="#tbl0001">Table 1</a>). It should be initiated with a planned treatment course until delivery or 4 weeks postpartum. <a class="elsevierStyleCrossRef" href="#bib0026">[26]</a> Despite the postpartum period being a vulnerable time for mothers with HBV, prolonged treatment beyond 4 weeks does not reduce risk of postpartum flares. <a class="elsevierStyleCrossRef" href="#bib0032">[32]</a> Newborns to mothers with chronic HBV should receive hepatitis B immune globulin and HBV vaccine within 12 h of birth. Similar to infants without maternal HBV exposure, exposed infants should receive all 3 doses of the HBV vaccination series. They should also undergo serologic testing of HBV between the age of 9 and 15 months. <a class="elsevierStyleCrossRef" href="#bib0026">[26]</a></p><p id="para0015" class="elsevierStylePara elsevierViewall">C-section delivery has not been shown to reduce vertical transmission and is not recommended. [<a class="elsevierStyleCrossRef" href="#bib0033">33</a>,<a class="elsevierStyleCrossRef" href="#bib0034">34</a>] Similarly, breastfeeding does not increase vertical transmission of HBV and is encouraged as long as appropriate immunoprophylaxis takes place. [<a class="elsevierStyleCrossRef" href="#bib0034">34</a>,<a class="elsevierStyleCrossRef" href="#bib0035">35</a>] HBV vaccination is safe in pregnancy and is recommended for women are not immune or infected. <a class="elsevierStyleCrossRef" href="#bib0027">[27]</a></p></span></span><span id="sec0013" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">5</span><span class="elsevierStyleSectionTitle" id="cesectitle0015">Hepatitis C virus (HCV)</span><span id="sec0014" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">5.1</span><span class="elsevierStyleSectionTitle" id="cesectitle0016">Maternal and fetal complications</span><p id="para0016" class="elsevierStylePara elsevierViewall">Chronic HCV infection has the potential to negatively impact pregnancy outcomes and increase the probability of complications for mother and fetus. [<a class="elsevierStyleCrossRef" href="#bib0036">36</a>,<a class="elsevierStyleCrossRef" href="#bib0037">37</a>] HCV's effects can be seen as early as conception with decreased chances of successful implantation and pregnancy occurring in women with active viral replication. <a class="elsevierStyleCrossRef" href="#bib0038">[38]</a> Maternal HCV is further associated with an increased incidence of preterm delivery(OR1.34; 95%CI 1.060–1.690), GDM (OR1.24; 95%CI 1.020–1.510), preeclampsia (OR1.206; 95%CI 0.935–1.556), and lower incidence of live birth(OR0.754; 95%CI 0.622–0.913)(<a class="elsevierStyleCrossRef" href="#tbl0002">Table 2</a>). <a class="elsevierStyleCrossRef" href="#bib0036">[36]</a> Furthermore, there is a greater risk of fetal growth restriction (OR1.53; 95%CI 1.40–1.68) and low birth weight (OR1.97; 95%CI 1.43–2.71). <a class="elsevierStyleCrossRef" href="#bib0039">[39]</a> There is no association between worse outcomes and levels of maternal viremia, which implies that isolated chronic HCV might not be the main culprit, but rather alternative factors such as advanced maternal liver disease, inadequate perinatal care, poor nutrition, and ongoing drug abuse may potentially contribute to poor outcomes. <a class="elsevierStyleCrossRef" href="#bib0040">[40]</a></p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">5.2</span><span class="elsevierStyleSectionTitle" id="cesectitle0017">Mother-to-Child transmission</span><p id="para0017" class="elsevierStylePara elsevierViewall">The US HCV prevalence rate noted in a 2011–2014 report increased 22%, among women of childbearing age. <a class="elsevierStyleCrossRef" href="#bib0041">[41]</a> Curative treatment prior to conception and achievement of a sustained virologic response(SVR) is the ideal transmission prevention strategy. Unfortunately, a mere 16% of individuals with HCV infection receive treatment and 9% achieve SVR. <a class="elsevierStyleCrossRef" href="#bib0042">[42]</a> Factors contributing to low treatment rates include lack of diagnosis awareness, inadequate access to healthcare, and poor compliance.</p><p id="para0018" class="elsevierStylePara elsevierViewall">HCV mother-to-child transmission is approximately 5.8%(95% CI 4.2%−7.8%) with the risk of transmission increasing to 10.8%(95%CI 7.6%−15.2%) in women with human immunodeficiency virus coinfection. <a class="elsevierStyleCrossRef" href="#bib0043">[43]</a> AASLD and Infectious Diseases Society of America(IDSA) currently recommend HCV screening for all pregnant women. <a class="elsevierStyleCrossRef" href="#bib0044">[44]</a> Among children vertically infected with HCV, 31% of infections are acquired intrauterine and 50% are acquired intrapartum. <a class="elsevierStyleCrossRef" href="#bib0045">[45]</a> Nevertheless, there is no evidence to suggest benefit with C-section delivery unless prolonged rupture of membranes or invasive monitoring are anticipated. <a class="elsevierStyleCrossRef" href="#bib0046">[46]</a></p><p id="para0019" class="elsevierStylePara elsevierViewall">Breastfeeding in HCV is safe as disease transmission is rare unless there are bleeding or cracked nipples. [<a class="elsevierStyleCrossRef" href="#bib0046">46</a>,<a class="elsevierStyleCrossRef" href="#bib0047">47</a>] Safety data on direct-acting antiviral therapy use in pregnancy is yet to be elucidated and society recommendations favor treatment either prior to conception or postpartum (after lactation). <a class="elsevierStyleCrossRef" href="#bib0046">[46]</a></p></span></span><span id="sec0016" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">6</span><span class="elsevierStyleSectionTitle" id="cesectitle0018">Non-alcoholic fatty liver disease (NAFLD)</span><p id="para0020" class="elsevierStylePara elsevierViewall">Given the escalating worldwide prevalence of NAFLD, understanding its effect on pregnancy outcomes is essential. Maternal NAFLD is associated with multiple pregnancy-related complications for both mother and fetus. Maternal NAFLD is associated with increased incidences of GDM (adjusted relative risk [aRR]2.78; 95%CI 1.25–6.15), preeclampsia (aRR1.95; 95%CI 1.03–3.70), C-section delivery (aRR1.52; 95%CI 1.19–1.94), preterm birth (aRR 2.50; 95%CI 1.38–4.55), and low birth weight (aRR2.40; 95% CI 1.21–4.78). <a class="elsevierStyleCrossRef" href="#bib0048">[48]</a> The management of NAFLD in pregnancy is similar to that in the non-pregnant patient and is centered around lifestyle modifications. Weight loss and a Mediterranean diet can decrease the incidence of GDM (OR0.67; 95%CI 0.53–0.84). <a class="elsevierStyleCrossRef" href="#bib0049">[49]</a> Mothers with NAFLD are encouraged to breastfeed. Data show an association of breastfeeding with decreased rates of nonalcoholic steatohepatitis (OR0.04; 95%CI 0.01–0.10) and hepatic fibrosis (OR0.32; 95%CI 0.16–0.65) in infants independent of maternal NASH presence. <a class="elsevierStyleCrossRef" href="#bib0050">[50]</a></p></span><span id="sec0017" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">7</span><span class="elsevierStyleSectionTitle" id="cesectitle0019">Autoimmune hepatitis (AIH)</span><p id="para0021" class="elsevierStylePara elsevierViewall">AIH directly impacts pregnancy with up to 38% of pregnancies leading to maternal complications and 33% of women experiencing disease flares. <a class="elsevierStyleCrossRef" href="#bib0051">[51]</a> Flares mostly occur after delivery. <a class="elsevierStyleCrossRef" href="#bib0052">[52]</a> AIH flares are more likely to occur in women who do not achieve remission for more than 1 year prior to conception (48.27%vs23.07%; <span class="elsevierStyleItalic">p</span> = 0.03), are older (29vs26 years; <span class="elsevierStyleItalic">p</span> = 0.047), or are not on treatment (50%vs26.22%; <span class="elsevierStyleItalic">p</span> = 0.048). <a class="elsevierStyleCrossRef" href="#bib0051">[51]</a> Disease flares are associated with hepatic decompensation (19.23%vs1.81%; <span class="elsevierStyleItalic">p</span> = 0.01) and increased incidence of neonatal intensive care admissions (50%vs7.27%; <span class="elsevierStyleItalic">p</span> = 0.047). Women with cirrhosis from AIH have a higher incidence of spontaneous abortion, preterm deliveries, hepatic decompensation, requirement for LT and mortality compared to women without cirrhosis. <a class="elsevierStyleCrossRef" href="#bib0051">[51]</a> Continuation of immunosuppressive therapy throughout the gestational and postpartum period is imperative to mitigate complications and ensure successful outcomes. <a class="elsevierStyleCrossRefs" href="#bib0051">[51–53]</a></p><p id="para0022" class="elsevierStylePara elsevierViewall">Management of AIH commonly includes the use of immunosuppressive agents such as prednisone and azathioprine(<a class="elsevierStyleCrossRef" href="#tbl0001">Table 1</a>). In inflammatory bowel disease (IBD), azathioprine use in pregnancy was demonstrated to be safe with no added risk of maternal or fetal complications, [<a class="elsevierStyleCrossRef" href="#bib0054">54</a>,<a class="elsevierStyleCrossRef" href="#bib0055">55</a>] although another meta-analysis, potentially confounded by concurrent medications and underlying disease activity, revealed an increased risk of preterm birth (OR1.67; 95%CI 1.26–2.20). <a class="elsevierStyleCrossRef" href="#bib0056">[56]</a> Fetal effects of azathioprine include bone marrow suppression, hygogammaglobulinemia, and thymic hypoplasia though these effects abate within 1 year of birth (<a class="elsevierStyleCrossRef" href="#tbl0001">Table 1</a>). <a class="elsevierStyleCrossRef" href="#bib0057">[57]</a> Maternal 6-Thioguanine nucleotide (6-TGN), a metabolite of azathioprine, has been shown to decrease during pregnancy. <a class="elsevierStyleCrossRef" href="#bib0058">[58]</a> Despite historical data linking its use in pregnancy to an increased risk of fetal orofacial clefts, corticosteroids remain safe and are recommended to maintain immunosuppression and optimize maternal and fetal outcomes. [<a class="elsevierStyleCrossRef" href="#bib0059">59</a>,<a class="elsevierStyleCrossRef" href="#bib0060">60</a>]</p><p id="para0023" class="elsevierStylePara elsevierViewall">For women with IBD, the Canadian Association of Gastroenterology in 2015 recommended continuation of azathioprine in pregnancy as studies demonstrated no increased teratogenicity risk. [<a class="elsevierStyleCrossRef" href="#bib0061">61</a>,<a class="elsevierStyleCrossRef" href="#bib0062">62</a>] Similarly, corticosteroids were also recommended for IBD flares. <a class="elsevierStyleCrossRef" href="#bib0061">[61]</a> The safe use of azathioprine, cyclosporine, corticosteroids, and tacrolimus in pregnancy has been demonstrated in post LT pregnancies with favorable neonatal outcomes. <a class="elsevierStyleCrossRef" href="#bib0063">[63]</a> Mycophenolate mofetil(MMF) should not be used in pregnancy as it increases risk of fetal malformations and first-trimester loss (<a class="elsevierStyleCrossRef" href="#tbl0001">Table 1</a>). [<a class="elsevierStyleCrossRef" href="#bib0064">64</a>,<a class="elsevierStyleCrossRef" href="#bib0065">65</a>]</p></span><span id="sec0018" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">8</span><span class="elsevierStyleSectionTitle" id="cesectitle0020">Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC)</span><p id="para0024" class="elsevierStylePara elsevierViewall">Appreciating the implications of PBC in pregnancy is especially important as 25% of those diagnosed are women of childbearing age. <a class="elsevierStyleCrossRef" href="#bib0066">[66]</a> Although data from 1968 reported a 75% rate of stillbirth or miscarriage, <a class="elsevierStyleCrossRef" href="#bib0067">[67]</a> recent data report 70–73% of women with stable liver function throughout pregnancy. [<a class="elsevierStyleCrossRef" href="#bib0068">68</a>,<a class="elsevierStyleCrossRef" href="#bib0069">69</a>] A case-control study comparing 186 women with PBC and 367 healthy women revealed a lower pregnancy rate (mean 1.91vs2.73; <span class="elsevierStyleItalic">p</span><0.05) and an increased incidence of perinatal and postnatal deaths and complications at childbirth (2.7%; <span class="elsevierStyleItalic">p</span><0.05) in PBC. <a class="elsevierStyleCrossRef" href="#bib0070">[70]</a> Another case-series involving 32 women with 50 pregnancies reported at least 1 live birth for 91% of women with no reports of maternal complications, hepatic decompensation, or death. <a class="elsevierStyleCrossRef" href="#bib0068">[68]</a> The reported live birth rate in PBC is 58%, which is lower than reported live birth rates for women with AIH (73%) and PSC (88%) (<a class="elsevierStyleCrossRef" href="#tbl0002">Table 2</a>). [<a class="elsevierStyleCrossRef" href="#bib0051">51</a>,<a class="elsevierStyleCrossRef" href="#bib0068">68</a>,<a class="elsevierStyleCrossRef" href="#bib0071">71</a>]</p><p id="para0025" class="elsevierStylePara elsevierViewall">Miscarriage in PBC occurs in 24%−40% of pregnancies. [<a class="elsevierStyleCrossRef" href="#bib0068">68</a>,<a class="elsevierStyleCrossRef" href="#bib0069">69</a>] Its probability has not been shown to be significantly impacted by degree of hepatic fibrosis or ursodeoxycholic acid (UDCA) use during pregnancy. Notably, 60–72% of women with PBC experience postpartum disease flares with more than half developing <span class="elsevierStyleItalic">de novo</span> pruritis requiring symptomatic treatment. [<a class="elsevierStyleCrossRef" href="#bib0068">68</a>,<a class="elsevierStyleCrossRef" href="#bib0069">69</a>] In a study comparing women with PBC and healthy matched-controls, those with PBC had higher rates of pruritis during pregnancy. <a class="elsevierStyleCrossRef" href="#bib0070">[70]</a> There are no clear risk factors for postpartum flares with no significant differences in women receiving UDCA and biochemical disease activity. <a class="elsevierStyleCrossRef" href="#bib0068">[68]</a> The majority of flares are mild and present as a transient elevation in serum alkaline phosphatase. [<a class="elsevierStyleCrossRef" href="#bib0068">68</a>,<a class="elsevierStyleCrossRef" href="#bib0069">69</a>]</p><p id="para0026" class="elsevierStylePara elsevierViewall">Maternal PSC is associated with a 3.63-fold (95%CI 2.35–5.61) increase in preterm deliveries and a 2.18-fold (95%CI 1.50–3.17) increase in C-section delivery with no increased risks of small for gestational age, stillbirths, or neonatal deaths. <a class="elsevierStyleCrossRef" href="#bib0072">[72]</a> A recent study involving pregnant women with PBC (<span class="elsevierStyleItalic">n</span> = 27) and PSC (<span class="elsevierStyleItalic">n</span> = 34) revealed no maternal complications throughout pregnancy including 59% receiving UDCA throughout gestation. Maternal PSC was associated with a 47% C-section delivery rate, although specific indications were not reported. <a class="elsevierStyleCrossRef" href="#bib0073">[73]</a> Preterm delivery was 27% for both PBC and PSC compared to the 2013 reported European average of 5.5–11%, though overall neonatal outcomes were favorable with a single stillbirth. [<a class="elsevierStyleCrossRef" href="#bib0073">73</a>,<a class="elsevierStyleCrossRef" href="#bib0074">74</a>] Gestational age was inversely proportional to early maternal serum alanine aminotransferase level (<span class="elsevierStyleItalic">R</span> = 0.34, <span class="elsevierStyleItalic">p</span> = 0.017) and late gestational bile acid level (<span class="elsevierStyleItalic">R</span> = 0.351, <span class="elsevierStyleItalic">p</span> = 0.033). <a class="elsevierStyleCrossRef" href="#bib0073">[73]</a></p><p id="para0027" class="elsevierStylePara elsevierViewall">Society recommendations support continuing UDCA throughout pregnancy. <a class="elsevierStyleCrossRef" href="#bib0013">[13]</a> Its use throughout gestation and breastfeeding has been associated with a favorable drug safety profile. [<a class="elsevierStyleCrossRef" href="#bib0069">69</a>,<a class="elsevierStyleCrossRef" href="#bib0075">75</a>] Pregnant women with PBC can develop portal hypertension from cirrhosis or nodular regenerative hyperplasia precirrhosis. <a class="elsevierStyleCrossRef" href="#bib0076">[76]</a> They should therefore undergo a screening endoscopy during the second trimester to evaluate for esophageal varices. <a class="elsevierStyleCrossRef" href="#bib0076">[76]</a></p></span><span id="sec0019" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">9</span><span class="elsevierStyleSectionTitle" id="cesectitle0021">Liver transplantation (LT)</span><p id="para0028" class="elsevierStylePara elsevierViewall">Approximately, 1 in 12 women undergoing LT are of reproductive age. <a class="elsevierStyleCrossRef" href="#bib0077">[77]</a> The number of reproductive age women who have undergone LT in the US is estimated to be 14,000 with 500 additional women undergoing LT every year. <a class="elsevierStyleCrossRef" href="#bib0078">[78]</a> Pre-LT infertility rates are high due to underlying cirrhosis. LT reverses cirrhosis-induced infertility and improves chances of conception.</p><p id="para0029" class="elsevierStylePara elsevierViewall">Post-LT pregnancy is associated with increased rates of hypertension, preeclampsia, preterm delivery, low birth weight, postpartum hemorrhage and requirement for C-section. <a class="elsevierStyleCrossRefs" href="#bib0077">[77–82]</a> Renal function impacts pregnancy outcomes with declining glomerular filtration rates correlating with shorter gestational periods. <a class="elsevierStyleCrossRef" href="#bib0083">[83]</a> The most common indications for C-section delivery are gestational hypertension, preeclampsia, placental abruption, breech presentation, failure to progress, and threatening intrauterine asphyxia. [<a class="elsevierStyleCrossRef" href="#bib0084">84</a>,<a class="elsevierStyleCrossRef" href="#bib0085">85</a>] There is no evidence of increased fetal or maternal mortality or allograft loss in pregnant post-LT recipients when conception occurs beyond 6 months of transplantation. Women are advised to delay conception by one year after undergoing LT due to increased risk of unstable immunosuppression and infection in the first year after transplantation which increases the risk of acute rejection. [<a class="elsevierStyleCrossRef" href="#bib0079">79</a>,<a class="elsevierStyleCrossRef" href="#bib0086">86</a>] Westbrook et al. revealed that women who conceived within 1 year of transplantation experienced higher rates of rejection. <a class="elsevierStyleCrossRef" href="#bib0079">[79]</a> Those with acute cellular rejection or poor graft function tend to fare worse and are advised to delay conception until 6–12 months after stability is reached. [<a class="elsevierStyleCrossRef" href="#bib0079">79</a>,<a class="elsevierStyleCrossRef" href="#bib0086">86</a>]</p><p id="para0030" class="elsevierStylePara elsevierViewall">Optimal pregnancy outcomes occur with adequate immunosuppression, stable allograft function, and sufficient control of underlying medical comorbidities. Tacrolimus is considered the ideal immunosuppressive agent of choice in pregnancy given its combined efficacy and safety (<a class="elsevierStyleCrossRef" href="#tbl0001">Table 1</a>). <a class="elsevierStyleCrossRef" href="#bib0087">[87]</a> As the maternal plasma volume increases throughout gestation, tacrolimus levels should be monitored and dosages adjusted accordingly. <a class="elsevierStyleCrossRef" href="#bib0088">[88]</a> Cyclosporine, azathioprine, and prednisone have been successfully used in pregnancy post transplantation (<a class="elsevierStyleCrossRef" href="#tbl0001">Table 1</a>). [<a class="elsevierStyleCrossRef" href="#bib0063">63</a>,<a class="elsevierStyleCrossRef" href="#bib0089">89</a>] The use of MMF is contraindicated in pregnancy and should be discontinued pre-conception. Instances of acute rejection should be managed similar to the non-pregnant patient. <a class="elsevierStyleCrossRef" href="#bib0087">[87]</a> Mammalian target of rapamycin inhibitors (mTOR) such as everolimus are increasingly used in post-LT patients particularly as a means to mitigate calcineurin inhibitor(CNI)-associated chronic kidney disease (<a class="elsevierStyleCrossRef" href="#tbl0001">Table 1</a>). <a class="elsevierStyleCrossRef" href="#bib0090">[90]</a> Early conversion from CNIs to mTORs has been shown to improve glomerular filtration rate but to date there is minimal information on pregnancy outcome. <a class="elsevierStyleCrossRef" href="#bib0090">[90]</a></p><p id="para0031" class="elsevierStylePara elsevierViewall">Historically, breastfeeding has been discouraged due to lack of safety data. <a class="elsevierStyleCrossRef" href="#bib0091">[91]</a> Recent data have demonstrated no adverse events on breastfed infants of mothers receiving tacrolimus post transplantation. [<a class="elsevierStyleCrossRef" href="#bib0092">92</a>,<a class="elsevierStyleCrossRef" href="#bib0093">93</a>] Similarly, azathioprine use is safe given negligible concentrations of its metabolites, 6-mercaptopurine (6-MP) and 6-TGN, in breast milk. [<a class="elsevierStyleCrossRef" href="#bib0094">94</a>,<a class="elsevierStyleCrossRef" href="#bib0095">95</a>]</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleLabel">10</span><span class="elsevierStyleSectionTitle" id="cesectitle0022">Conclusion</span><p id="para0032" class="elsevierStylePara elsevierViewall">Chronic liver disease carries significant pregnancy-related implications for women. Pregnancy in women with cirrhosis is uncommon and when present, portends increased gestational and perinatal risks for mother and child. With improvement in cirrhosis management pre-conception, fertility and improved outcomes are expected to follow suit. Appropriate counseling, adequate awareness of increased risks, and disease-specific management are key factors for success. Improvement in chronic liver disease management and post-LT care over the years has enhanced maternal and fetal outcomes. <a class="elsevierStyleCrossRef" href="#tbl0001">Table 1</a> summarizes pregnancy and lactation risks of specific medications commonly used in chronic liver disease. [<a class="elsevierStyleCrossRef" href="#bib0091">91</a>,<a class="elsevierStyleCrossRefs" href="#bib0096">96–107</a>] <a class="elsevierStyleCrossRef" href="#tbl0002">Table 2</a> displays the gestational and postpartum risk profile of several chronic liver diseases. Pregnancy in women with cirrhosis is plausible though remains high-risk. Appropriate management compels a multidisciplinary approach involving high-risk obstetricians, hepatologists, anesthesiologists, and pediatricians.<span class="elsevierStyleDefList"><span class="elsevierStyleSectionTitle" id="cesectitle0023">Abbreviations</span><span class="elsevierStyleDefTerm">LT</span><span class="elsevierStyleDefDescription"><p id="para0033" class="elsevierStylePara elsevierViewall">liver transplantation</p></span><span class="elsevierStyleDefTerm">NIS</span><span class="elsevierStyleDefDescription"><p id="para0034" class="elsevierStylePara elsevierViewall">nationwide inpatient sample</p></span><span class="elsevierStyleDefTerm">OR</span><span class="elsevierStyleDefDescription"><p id="para0035" class="elsevierStylePara elsevierViewall">odds ratio</p></span><span class="elsevierStyleDefTerm">CI</span><span class="elsevierStyleDefDescription"><p id="para0036" class="elsevierStylePara elsevierViewall">confidence interval</p></span><span class="elsevierStyleDefTerm">aOR</span><span class="elsevierStyleDefDescription"><p id="para0037" class="elsevierStylePara elsevierViewall">adjusted OR</p></span><span class="elsevierStyleDefTerm">AASLD</span><span class="elsevierStyleDefDescription"><p id="para0038" class="elsevierStylePara elsevierViewall">american association for the study of liver diseases</p></span><span class="elsevierStyleDefTerm">GDM</span><span class="elsevierStyleDefDescription"><p id="para0039" class="elsevierStylePara elsevierViewall">gestational diabetes mellitus</p></span><span class="elsevierStyleDefTerm">MELD</span><span class="elsevierStyleDefDescription"><p id="para0040" class="elsevierStylePara elsevierViewall">model for end stage liver disease</p></span><span class="elsevierStyleDefTerm">HBV</span><span class="elsevierStyleDefDescription"><p id="para0041" class="elsevierStylePara elsevierViewall">hepatitis B virus</p></span><span class="elsevierStyleDefTerm">TDF</span><span class="elsevierStyleDefDescription"><p id="para0042" class="elsevierStylePara elsevierViewall">tenofovir disoproxil fumarate</p></span><span class="elsevierStyleDefTerm">HCV</span><span class="elsevierStyleDefDescription"><p id="para0043" class="elsevierStylePara elsevierViewall">hepatitis C virus</p></span><span class="elsevierStyleDefTerm">SVR</span><span class="elsevierStyleDefDescription"><p id="para0044" class="elsevierStylePara elsevierViewall">Sustained Virologic Response</p></span><span class="elsevierStyleDefTerm">IDSA</span><span class="elsevierStyleDefDescription"><p id="para0045" class="elsevierStylePara elsevierViewall">Infectious Disease Society of America</p></span><span class="elsevierStyleDefTerm">NAFLD</span><span class="elsevierStyleDefDescription"><p id="para0046" class="elsevierStylePara elsevierViewall">non-alcoholic fatty liver disease</p></span><span class="elsevierStyleDefTerm">aRR</span><span class="elsevierStyleDefDescription"><p id="para0047" class="elsevierStylePara elsevierViewall">adjusted relative risk</p></span><span class="elsevierStyleDefTerm">AIH</span><span class="elsevierStyleDefDescription"><p id="para0048" class="elsevierStylePara elsevierViewall">autoimmune hepatitis</p></span><span class="elsevierStyleDefTerm">6-TGN</span><span class="elsevierStyleDefDescription"><p id="para0049" class="elsevierStylePara elsevierViewall">6-thioguanine nucleotide</p></span><span class="elsevierStyleDefTerm">PBC</span><span class="elsevierStyleDefDescription"><p id="para0050" class="elsevierStylePara elsevierViewall">primary biliary cirrhosis</p></span><span class="elsevierStyleDefTerm">PSC</span><span class="elsevierStyleDefDescription"><p id="para0051" class="elsevierStylePara elsevierViewall">primary sclerosing cholangitis</p></span><span class="elsevierStyleDefTerm">MMF</span><span class="elsevierStyleDefDescription"><p id="para0052" class="elsevierStylePara elsevierViewall">mycophenolate mofetil</p></span><span class="elsevierStyleDefTerm">UDCA</span><span class="elsevierStyleDefDescription"><p id="para0053" class="elsevierStylePara elsevierViewall">ursodeoxycholic acid</p></span><span class="elsevierStyleDefTerm">mTOR</span><span class="elsevierStyleDefDescription"><p id="para0054" class="elsevierStylePara elsevierViewall">mammalian target of rapamycin receptor</p></span><span class="elsevierStyleDefTerm">CNI</span><span class="elsevierStyleDefDescription"><p id="para0055" class="elsevierStylePara elsevierViewall">calcineurin inhibitor</p></span><span class="elsevierStyleDefTerm">6-MP</span><span class="elsevierStyleDefDescription"><p id="para0056" class="elsevierStylePara elsevierViewall">6-mercaptopurine</p></span></span></p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:14 [ 0 => array:3 [ "identificador" => "xres1761532" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abss0001" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1549128" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "sec0001" "titulo" => "Introduction" ] 3 => array:2 [ "identificador" => "sec0002" "titulo" => "Search strategy" ] 4 => array:3 [ "identificador" => "sec0003" "titulo" => "General considerations" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0004" "titulo" => "Impact on fertility" ] 1 => array:2 [ "identificador" => "sec0005" "titulo" => "Maternal complications" ] 2 => array:2 [ "identificador" => "sec0006" "titulo" => "Fetal complications" ] 3 => array:2 [ "identificador" => "sec0007" "titulo" => "Mode of delivery" ] 4 => array:2 [ "identificador" => "sec0008" "titulo" => "Prognostication" ] ] ] 5 => array:3 [ "identificador" => "sec0009" "titulo" => "Disease-Specific implications to pregnancy: Hepatitis B virus (HBV)" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0010" "titulo" => "Maternal and fetal complications" ] 1 => array:2 [ "identificador" => "sec0011" "titulo" => "Mother-to-Child transmission" ] 2 => array:2 [ "identificador" => "sec0012" "titulo" => "Management of HBV in pregnancy" ] ] ] 6 => array:3 [ "identificador" => "sec0013" "titulo" => "Hepatitis C virus (HCV)" "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0014" "titulo" => "Maternal and fetal complications" ] 1 => array:2 [ "identificador" => "sec0015" "titulo" => "Mother-to-Child transmission" ] ] ] 7 => array:2 [ "identificador" => "sec0016" "titulo" => "Non-alcoholic fatty liver disease (NAFLD)" ] 8 => array:2 [ "identificador" => "sec0017" "titulo" => "Autoimmune hepatitis (AIH)" ] 9 => array:2 [ "identificador" => "sec0018" "titulo" => "Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC)" ] 10 => array:2 [ "identificador" => "sec0019" "titulo" => "Liver transplantation (LT)" ] 11 => array:2 [ "identificador" => "sec0020" "titulo" => "Conclusion" ] 12 => array:2 [ "identificador" => "xack622264" "titulo" => "Funding" ] 13 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1549128" "palabras" => array:4 [ 0 => "Chronic liver disease" 1 => "Cirrhosis" 2 => "Liver transplantation" 3 => "Pregnancy" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abss0001" class="elsevierStyleSection elsevierViewall"><p id="spara006" class="elsevierStyleSimplePara elsevierViewall">Chronic liver disease poses various challenges for women of reproductive age. Cirrhosis, particularly if decompensated, and liver transplantation may impact gestation and perinatal outcomes. Tailored management of underlying liver disease is critical to optimize maternal and fetal wellbeing. Early education, timely intervention, close monitoring, and a multidisciplinary approach are key elements required to minimize complications and increase chances of a safe and successful pregnancy. In this review, we focus on the pregnancy-related implications of chronic liver disease and liver transplantation on women of reproductive age and highlight disease-specific management considerations.</p></span>" ] ] "multimedia" => array:2 [ 0 => array:8 [ "identificador" => "tbl0001" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0001" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spara002" class="elsevierStyleSimplePara elsevierViewall">Abbreviations: FDA, Food and Drug Administration; TDF, Tenofovir disoproxil fumarate; UDCA, Ursodeoxycholic acid, LT, Liver Transplantation, mTOR, Mammalian target of rapamycin.</p><p id="spara003" class="elsevierStyleSimplePara elsevierViewall">*Also used in LT.</p>" "tablatextoimagen" => array:1 [ 0 => array:1 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><a name="en0001"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Etiology \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0002"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Medication \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0003"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Present in Human Breast Milk \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0004"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Pregnancy and Lactation – Compatibility and Risks \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><a name="en0005"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Cirrhosis \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0006"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Propranolol \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0007"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Yes (low) <a class="elsevierStyleCrossRef" href="#bib0096">[96]</a> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0008"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><ul class="elsevierStyleList" id="celist0001"><li class="elsevierStyleListItem" id="celistitem0001"><span class="elsevierStyleLabel">•</span><p id="para0059" class="elsevierStylePara elsevierViewall">Risk of neonatal hypoglycemia, bradycardia, intrauterine growth retardation</p></li><li class="elsevierStyleListItem" id="celistitem0002"><span class="elsevierStyleLabel">•</span><p id="para0060" class="elsevierStylePara elsevierViewall">Compatible with breastfeeding <a class="elsevierStyleCrossRef" href="#bib0097">[97]</a></p></li></ul> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0009"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Hepatitis B Virus \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0010"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Tenofovir disoproxil fumarate \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0011"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Yes (low) <a class="elsevierStyleCrossRef" href="#bib0098">[98]</a> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0012"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><ul class="elsevierStyleList" id="celist0002"><li class="elsevierStyleListItem" id="celistitem0003"><span class="elsevierStyleLabel">•</span><p id="para0061" class="elsevierStylePara elsevierViewall">Preferred choice in pregnancy due to increased potency & lower resistance <a class="elsevierStyleCrossRef" href="#bib0026">[26]</a></p></li><li class="elsevierStyleListItem" id="celistitem0004"><span class="elsevierStyleLabel">•</span><p id="para0062" class="elsevierStylePara elsevierViewall">Breastfeeding not contraindicated though unknown risk of exposure to infants should be discussed <a class="elsevierStyleCrossRef" href="#bib0026">[26]</a></p></li></ul> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0013"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0014"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Lamivudine \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0015"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Yes (low) <a class="elsevierStyleCrossRef" href="#bib0099">[99]</a> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0016"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><ul class="elsevierStyleList" id="celist0003"><li class="elsevierStyleListItem" id="celistitem0005"><span class="elsevierStyleLabel">•</span><p id="para0063" class="elsevierStylePara elsevierViewall">TDF preferred to minimize risk of viral resistance <a class="elsevierStyleCrossRef" href="#bib0026">[26]</a></p></li><li class="elsevierStyleListItem" id="celistitem0006"><span class="elsevierStyleLabel">•</span><p id="para0064" class="elsevierStylePara elsevierViewall">Breastfeeding not contraindicated though unknown risk of exposure to infants should be discussed <a class="elsevierStyleCrossRef" href="#bib0026">[26]</a></p></li></ul> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0017"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0018"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Entecavir \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0019"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Unknown \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0020"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><ul class="elsevierStyleList" id="celist0004"><li class="elsevierStyleListItem" id="celistitem0007"><span class="elsevierStyleLabel">•</span><p id="para0065" class="elsevierStylePara elsevierViewall">No adequate or well-controlled studies in pregnant women</p></li><li class="elsevierStyleListItem" id="celistitem0008"><span class="elsevierStyleLabel">•</span><p id="para0066" class="elsevierStylePara elsevierViewall">Breastfeeding not recommended due to unknown fetal risk</p></li></ul> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0021"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Hepatitis C Virus \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0022"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Ribavirin \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0023"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Unknown \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0024"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><ul class="elsevierStyleList" id="celist0005"><li class="elsevierStyleListItem" id="celistitem0009"><span class="elsevierStyleLabel">•</span><p id="para0067" class="elsevierStylePara elsevierViewall">Contraindicated in pregnancy</p></li></ul> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0025"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0026"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Ledipasvir/sofosbuvir \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0027"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Unknown \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0028"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><ul class="elsevierStyleList" id="celist0006"><li class="elsevierStyleListItem" id="celistitem0010"><span class="elsevierStyleLabel">•</span><p id="para0068" class="elsevierStylePara elsevierViewall">Treatment ideal before conception</p></li></ul> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0029"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0030"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Elbasvir/grazoprevir \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0031"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Unknown \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0032"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><ul class="elsevierStyleList" id="celist0007"><li class="elsevierStyleListItem" id="celistitem0011"><span class="elsevierStyleLabel">•</span><p id="para0069" class="elsevierStylePara elsevierViewall">Treatment ideal before conception</p></li></ul> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0033"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Autoimmune Hepatitis \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0034"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Azathioprine* \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0035"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Yes (low) <a class="elsevierStyleCrossRef" href="#bib0094">[94]</a> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0036"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><ul class="elsevierStyleList" id="celist0008"><li class="elsevierStyleListItem" id="celistitem0012"><span class="elsevierStyleLabel">•</span><p id="para0070" class="elsevierStylePara elsevierViewall">Safely used in pregnancy in IBD <a class="elsevierStyleCrossRef" href="#bib0054">[54]</a></p></li><li class="elsevierStyleListItem" id="celistitem0013"><span class="elsevierStyleLabel">•</span><p id="para0071" class="elsevierStylePara elsevierViewall">Safely used in maintenance of graft function in pregnancy after LT <a class="elsevierStyleCrossRef" href="#bib0063">[63]</a></p></li><li class="elsevierStyleListItem" id="celistitem0014"><span class="elsevierStyleLabel">•</span><p id="para0072" class="elsevierStylePara elsevierViewall">Fetal effects include bone marrow suppression, hypogammaglobulinemia, and thymic hypoplasia though effects are reversed within 1 year of birth <a class="elsevierStyleCrossRef" href="#bib0057">[57]</a></p></li><li class="elsevierStyleListItem" id="celistitem0015"><span class="elsevierStyleLabel">•</span><p id="para0073" class="elsevierStylePara elsevierViewall">Compatible with breastfeeding [<a class="elsevierStyleCrossRef" href="#bib0094">94</a>,<a class="elsevierStyleCrossRef" href="#bib0095">95</a>]</p></li></ul> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0037"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0038"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Corticosteroids* \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0039"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Yes (very low) <a class="elsevierStyleCrossRef" href="#bib0100">[100]</a> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0040"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><ul class="elsevierStyleList" id="celist0009"><li class="elsevierStyleListItem" id="celistitem0016"><span class="elsevierStyleLabel">•</span><p id="para0074" class="elsevierStylePara elsevierViewall">Recommended for IBD flares in pregnancy <a class="elsevierStyleCrossRef" href="#bib0061">[61]</a></p></li><li class="elsevierStyleListItem" id="celistitem0017"><span class="elsevierStyleLabel">•</span><p id="para0075" class="elsevierStylePara elsevierViewall">Safely used for control of graft deterioration in pregnancy post LT <a class="elsevierStyleCrossRef" href="#bib0063">[63]</a></p></li><li class="elsevierStyleListItem" id="celistitem0018"><span class="elsevierStyleLabel">•</span><p id="para0076" class="elsevierStylePara elsevierViewall">Historically associated with orofacial clefts though more recent data demonstrate no added risk [<a class="elsevierStyleCrossRef" href="#bib0059">59</a>,<a class="elsevierStyleCrossRef" href="#bib0060">60</a>]</p></li><li class="elsevierStyleListItem" id="celistitem0019"><span class="elsevierStyleLabel">•</span><p id="para0077" class="elsevierStylePara elsevierViewall">Compatible with breastfeeding <a class="elsevierStyleCrossRef" href="#bib0101">[101]</a></p></li></ul> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0041"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0042"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Mycophenolate mofetil* \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0043"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Unknown \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0044"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><ul class="elsevierStyleList" id="celist0010"><li class="elsevierStyleListItem" id="celistitem0020"><span class="elsevierStyleLabel">•</span><p id="para0078" class="elsevierStylePara elsevierViewall">Contraindicated in pregnancy due to increased risk of fetal malformations and first trimester pregnancy loss <a class="elsevierStyleCrossRef" href="#bib0107">[107]</a></p></li><li class="elsevierStyleListItem" id="celistitem0021"><span class="elsevierStyleLabel">•</span><p id="para0079" class="elsevierStylePara elsevierViewall">No adequate or well-controlled studies in lactating women</p></li></ul> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0045"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0046"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Cyclosporine* \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0047"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Yes <a class="elsevierStyleCrossRef" href="#bib0106">[106]</a> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0048"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><ul class="elsevierStyleList" id="celist0011"><li class="elsevierStyleListItem" id="celistitem0022"><span class="elsevierStyleLabel">•</span><p id="para0080" class="elsevierStylePara elsevierViewall">Increased risk of premature birth and small for gestational age births <a class="elsevierStyleCrossRef" href="#bib0102">[102]</a></p></li><li class="elsevierStyleListItem" id="celistitem0023"><span class="elsevierStyleLabel">•</span><p id="para0081" class="elsevierStylePara elsevierViewall">Benefits in controlling hepatic disease might outweigh teratogenicity risks</p></li><li class="elsevierStyleListItem" id="celistitem0024"><span class="elsevierStyleLabel">•</span><p id="para0082" class="elsevierStylePara elsevierViewall">Safely used in maintenance of graft function in pregnancy after LT <a class="elsevierStyleCrossRef" href="#bib0063">[63]</a></p></li><li class="elsevierStyleListItem" id="celistitem0025"><span class="elsevierStyleLabel">•</span><p id="para0083" class="elsevierStylePara elsevierViewall">Breastfeeding not recommended per FDA though successful outcomes in exposed infants have been reported <a class="elsevierStyleCrossRef" href="#bib0089">[89]</a></p></li></ul> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0049"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0050"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Ursodeoxycholic acid \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0051"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Yes (low) <a class="elsevierStyleCrossRef" href="#bib0103">[103]</a> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0052"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><ul class="elsevierStyleList" id="celist0012"><li class="elsevierStyleListItem" id="celistitem0026"><span class="elsevierStyleLabel">•</span><p id="para0084" class="elsevierStylePara elsevierViewall">No reported fetal side effects in mothers receiving UDCA throughout gestation <a class="elsevierStyleCrossRef" href="#bib0069">[69]</a></p></li><li class="elsevierStyleListItem" id="celistitem0027"><span class="elsevierStyleLabel">•</span><p id="para0085" class="elsevierStylePara elsevierViewall">Compatible with breastfeeding <a class="elsevierStyleCrossRef" href="#bib0104">[104]</a></p></li><li class="elsevierStyleListItem" id="celistitem0028"><span class="elsevierStyleLabel">•</span><p id="para0086" class="elsevierStylePara elsevierViewall">Recommend continuation throughout pregnancy</p></li></ul> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0053"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0054"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Obeticholic acid \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0055"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Unknown \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0056"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><ul class="elsevierStyleList" id="celist0013"><li class="elsevierStyleListItem" id="celistitem0029"><span class="elsevierStyleLabel">•</span><p id="para0087" class="elsevierStylePara elsevierViewall">No adequate or well-controlled studies in pregnant or lactating women</p></li></ul> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0057"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Liver Transplantation(LT) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0058"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Tacrolimus \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0059"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Yes (low) <a class="elsevierStyleCrossRef" href="#bib0105">[105]</a> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0060"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><ul class="elsevierStyleList" id="celist0014"><li class="elsevierStyleListItem" id="celistitem0030"><span class="elsevierStyleLabel">•</span><p id="para0088" class="elsevierStylePara elsevierViewall">Recommended in pregnancy for maintenance of immunosuppression <a class="elsevierStyleCrossRef" href="#bib0087">[87]</a></p></li><li class="elsevierStyleListItem" id="celistitem0031"><span class="elsevierStyleLabel">•</span><p id="para0089" class="elsevierStylePara elsevierViewall">Safely used in maintenance of graft function in pregnancy after LT <a class="elsevierStyleCrossRef" href="#bib0063">[63]</a></p></li><li class="elsevierStyleListItem" id="celistitem0032"><span class="elsevierStyleLabel">•</span><p id="para0090" class="elsevierStylePara elsevierViewall">Compatible with breastfeeding <a class="elsevierStyleCrossRef" href="#bib0092">[92]</a></p></li></ul> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0061"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0062"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Everolimus and sirolimus (mTOR inhibitors) \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0063"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Yes <a class="elsevierStyleCrossRef" href="#bib0108">[108]</a> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0064"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"><ul class="elsevierStyleList" id="celist0015"><li class="elsevierStyleListItem" id="celistitem0033"><span class="elsevierStyleLabel">•</span><p id="para0091" class="elsevierStylePara elsevierViewall">Use in pregnancy not recommended due to reports of miscarriages <a class="elsevierStyleCrossRef" href="#bib0109">[109]</a></p></li><li class="elsevierStyleListItem" id="celistitem0034"><span class="elsevierStyleLabel">•</span><p id="para0092" class="elsevierStylePara elsevierViewall">Use while breastfeeding not recommended due to scarce data on humans</p></li><li class="elsevierStyleListItem" id="celistitem0035"><span class="elsevierStyleLabel">•</span><p id="para0093" class="elsevierStylePara elsevierViewall">Successful maternal and fetal outcomes have been reported in case reports [<a class="elsevierStyleCrossRef" href="#bib0110">110</a>,<a class="elsevierStyleCrossRef" href="#bib0111">111</a>]</p></li></ul> \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spara001" class="elsevierStyleSimplePara elsevierViewall">Pregnancy and lactation risks for medications commonly utilized in several chronic liver disease etiologies.</p>" ] ] 1 => array:8 [ "identificador" => "tbl0002" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "alt0002" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spara005" class="elsevierStyleSimplePara elsevierViewall">Abbreviations: NAFLD, Non-alcoholic Fatty Liver Disease; OR, Odds Ratio; aRR, adjusted Relative Risk; CI, Confidence Interval, N/A Not available.</p>" "tablatextoimagen" => array:1 [ 0 => array:1 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><a name="en0065"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">OutcomesChronicLiverDisease \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0066"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Maternal Mortality \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0067"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Live Birth Rate \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0068"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Preterm Delivery \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0069"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">fetal intra-uterine growth restriction \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0070"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">cesarian section \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0071"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Preeclampsia \t\t\t\t\t\t\n \t\t\t\t\t\t</th><a name="en0072"></a><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="top" scope="col" style="border-bottom: 2px solid black">Gestational Diabetes Mellitus \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><a name="en0073"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Cirrhosis [<a class="elsevierStyleCrossRef" href="#bib0003">3</a>,<a class="elsevierStyleCrossRef" href="#bib0018">18</a>] \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0074"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">6% in decompensated cirrhosis \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0075"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">58% \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0076"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">OR 1.51; 95% CI 4.16–7.30 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0077"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">OR 2.70; 95% CI 1.47–4.96 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0078"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">OR 1.41; 95% CI 1.06–1.88 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0079"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">OR 1.78; 95% CI 1.15–2.78 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0080"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0081"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Hepatitis B<span class="elsevierStyleSup">22</span> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0082"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">No Significant Difference \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0083"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">OR 2.04; 95% CI 1.21–3.44 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0084"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0085"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0086"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0087"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0088"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0089"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Hepatitis C<span class="elsevierStyleSup">36,39</span> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0090"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0091"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">OR 0.754; 95% CI 0.622–0.913 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0092"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">OR 1.336; 95% CI 1.059–1.685 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0093"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">OR 1.53; 95% CI 1.40–1.68 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0094"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0095"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0096"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">OR 1.24; 95% CI 1.020–1.510 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0097"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Autoimmune Hepatitis <a class="elsevierStyleCrossRef" href="#bib0051">[51]</a> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0098"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0099"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">73% \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0100"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">20% \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0101"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0102"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0103"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0104"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0105"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Primary Biliary Cirrhosis <a class="elsevierStyleCrossRefs" href="#bib0068">[68–70]</a> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0106"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0107"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">58% \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0108"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">16% \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0109"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0110"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">OR 0.52; 95% CI 0.29–0.94 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0111"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0112"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0113"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Primary Sclerosing Cholangitis [<a class="elsevierStyleCrossRef" href="#bib0071">71</a>,<a class="elsevierStyleCrossRef" href="#bib0072">72</a>] \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0114"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0115"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">88% \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0116"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">OR 3.63; 95% CI 2.35–5.61 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0117"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0118"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">OR 2.18; 95% CI 1.50–3.17 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0119"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">OR 1.33; 95% CI 0.62–2.83 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0120"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0121"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">NAFLD <a class="elsevierStyleCrossRef" href="#bib0048">[48]</a> \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0122"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0123"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0124"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">aRR 2.50; 95% CI 1.38–4.55 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0125"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">aRR 2.40; 95% CI 1.21–4.78 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0126"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">aRR 1.52; 95% CI 1.19–1.94 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0127"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">aRR 1.95; 95% CI 1.03–3.70 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0128"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">aRR 2.78; 95% CI 1.25–6.15 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><a name="en0129"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">Liver Transplantation(LT) [<a class="elsevierStyleCrossRef" href="#bib0078">78</a>,<a class="elsevierStyleCrossRef" href="#bib0080">80</a>] \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0130"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">N/A \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0131"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">76.9% \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0132"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">39.4%; 95% CI 33.1%−46.0% \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0133"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">OR 4.1, 95% CI 2.1–7.7 \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0134"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">44.6%; 95% CI 39.2%−50.1% \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0135"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">21.9%; 95% CI 17.7%−26.4% \t\t\t\t\t\t\n \t\t\t\t</td><a name="en0136"></a><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="top">OR 1.9, 95% CI 1.0–3.5 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spara004" class="elsevierStyleSimplePara elsevierViewall">Pregnancy-related complication risk profile for various chronic liver disease etiologies.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "cebibsec1" "bibliografiaReferencia" => array:111 [ 0 => array:3 [ "identificador" => "bib0001" "etiqueta" => "[1]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: a Silent Epidemic" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10620-017-4492-3" "Revista" => array:7 [ "tituloSerie" => "Dig Dis Sci" "fecha" => "2017" "volumen" => "62" "numero" => "5" "paginaInicial" => "1373" "paginaFinal" => "1380" "link" => array:1 [ …1] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0002" "etiqueta" => "[2]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The Epidemiology of Cirrhosis in the United States: a Population-based Study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MCG.0000000000000208" "Revista" => array:7 [ "tituloSerie" => "J Clin Gastroenterol" "fecha" => "2015" "volumen" => "49" "numero" => "8" "paginaInicial" => "690" "paginaFinal" => "696" "link" => array:1 [ …1] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0003" "etiqueta" => "[3]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The outcomes of pregnancy in patients with cirrhosis: a population-based study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1478-3231.2009.02153.x" "Revista" => array:7 [ "tituloSerie" => "Liver Int" "fecha" => "2010" "volumen" => "30" "numero" => "2" "paginaInicial" => "275" "paginaFinal" => "283" "link" => array:1 [ …1] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0004" "etiqueta" => "[4]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gynecological and reproductive function after liver transplantation" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/00007890-199608270-00009" "Revista" => array:7 [ "tituloSerie" => "Transplantation" "fecha" => "1996" "volumen" => "62" "numero" => "4" "paginaInicial" => "476" "paginaFinal" => "479" "link" => array:1 [ …1] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0005" "etiqueta" => "[5]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Menstrual Function in Female Liver Transplant Recipients of Reproductive Age" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.transproceed.2009.03.073" "Revista" => array:7 [ "tituloSerie" => "Transplant Proc" "fecha" => "2009" "volumen" => "41" "numero" => "5" "paginaInicial" => "1735" "paginaFinal" => "1739" "link" => array:1 [ …1] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0006" "etiqueta" => "[6]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/1471-0528.17156" "Revista" => array:7 [ "tituloSerie" => "Medical and Obstetric Complications Among Pregnant Women With Liver Cirrhosis, Obstetrics & Gynecology" "fecha" => "2017 Jun" "volumen" => "129" "numero" => "6" "paginaInicial" => "1118" "paginaFinal" => "1123" "link" => array:1 [ …1] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0007" "etiqueta" => "[7]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Influence of Age and Gender Before and After Liver Transplantation: influence of Age and Gender" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/lt.23574" "Revista" => array:7 [ "tituloSerie" => "Liver Transpl" "fecha" => "2013" "volumen" => "19" "numero" => "2" "paginaInicial" => "122" "paginaFinal" => "134" "link" => array:1 [ …1] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0008" "etiqueta" => "[8]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Haug E. Inappropriately low levels of gonadotrophins in amenorrhoeic women with alcoholic and non-alcoholic cirrhosis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1530/eje.0.1320444" "Revista" => array:8 [ "tituloSerie" => "Eur J Endocrinol" "fecha" => "1995" "volumen" => "132" "numero" => "4" "paginaInicial" => "444" "paginaFinal" => "449" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0009" "etiqueta" => "[9]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impact of Cirrhosis and Liver Transplant on Maternal Health During Labor and Delivery" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Clin Gastroenterol Hepatol" "fecha" => "2009" "volumen" => "7" "numero" => "12" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0010" "etiqueta" => "[10]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy and esophageal varices" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/0002-9610(82)90190-8" "Revista" => array:7 [ "tituloSerie" => "Am J Surg" "fecha" => "1982" "volumen" => "143" "numero" => "4" "paginaInicial" => "421" "paginaFinal" => "425" "link" => array:1 [ …1] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0011" "etiqueta" => "[11]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy and Extrahepatic Portal Hypertension" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000293268" "Revista" => array:7 [ "tituloSerie" => "Gynecol Obstet Invest" "fecha" => "1990" "volumen" => "30" "numero" => "4" "paginaInicial" => "193" "paginaFinal" => "197" "link" => array:1 [ …1] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0012" "etiqueta" => "[12]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Non-cirrhotic portal hypertension in pregnancy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Int J Gynecol Obstet" "fecha" => "2001" "volumen" => "72" "numero" => "1" "paginaInicial" => "1" "paginaFinal" => "7" ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0013" "etiqueta" => "[13]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "ACG Clinical Guideline: liver Disease and Pregnancy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ajg.2015.430" "Revista" => array:7 [ "tituloSerie" => "Am J Gastroenterol" "fecha" => "2016" "volumen" => "111" "numero" => "2" "paginaInicial" => "176" "paginaFinal" => "194" "link" => array:1 [ …1] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0014" "etiqueta" => "[14]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Transjugular Intrahepatic Portosystemic Shunt Placement During Pregnancy: a Case Series of Five Patients" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00270-015-1053-z" "Revista" => array:7 [ "tituloSerie" => "Cardiovasc Intervent Radiol" "fecha" => "2015" "volumen" => "38" "numero" => "5" "paginaInicial" => "1205" "paginaFinal" => "1210" "link" => array:1 [ …1] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0015" "etiqueta" => "[15]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of the valsalva maneuver on portal hypertension in cirrhosis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/00000441-195406000-00010" "Revista" => array:7 [ "tituloSerie" => "Am J Med Sci" "fecha" => "1954" "volumen" => "227" "numero" => "6" "paginaInicial" => "661" "paginaFinal" => "662" "link" => array:1 [ …1] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0016" "etiqueta" => "[16]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Elective forceps delivery and extradural anaesthesia in a primigravida with portal hypertension and oesophageal varices" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/bja/76.2.325" "Revista" => array:7 [ "tituloSerie" => "Br J Anaesth" "fecha" => "1996" "volumen" => "76" "numero" => "2" "paginaInicial" => "325" "paginaFinal" => "327" "link" => array:1 [ …1] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0017" "etiqueta" => "[17]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "PREGNANCY IN A PATIENT WITH PORTAL HYPERTENSION" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Liver Dis" "fecha" => "1999" "volumen" => "3" "numero" => "1" "paginaInicial" => "147" "paginaFinal" => "162" ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0018" "etiqueta" => "[18]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Model for End-Stage Liver Disease Score Predicts Outcome in Cirrhotic Patients During Pregnancy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cgh.2011.03.036" "Revista" => array:7 [ "tituloSerie" => "Clin Gastroenterol Hepatol" "fecha" => "2011" "volumen" => "9" "numero" => "8" "paginaInicial" => "694" "paginaFinal" => "699" "link" => array:1 [ …1] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0019" "etiqueta" => "[19]" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "World Health Organization, World Health Organization, Global Hepatitis Programme. Global hepatitis report, 2017 [Internet]. 2017 [cited 2020 Jun 29]. Available from: http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1" ] ] ] 19 => array:3 [ "identificador" => "bib0020" "etiqueta" => "[20]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effect of hepatitis B antigenemia on pregnancy outcome" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/0002-9378(88)90010-5" "Revista" => array:7 [ "tituloSerie" => "Am J Obstet Gynecol" "fecha" => "1988" "volumen" => "158" "numero" => "3" "paginaInicial" => "486" "paginaFinal" => "489" "link" => array:1 [ …1] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0021" "etiqueta" => "[21]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hepatitis B surface antigen carrier status and its correlation to gestational hypertension" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1046/j.0004-8666.2003.00029.x" "Revista" => array:8 [ "tituloSerie" => "Aust N Z J Obstet Gynaecol" "fecha" => "2003" "volumen" => "43" "numero" => "2" "paginaInicial" => "119" "paginaFinal" => "122" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0022" "etiqueta" => "[22]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The impact of maternal HBsAg carrier status on pregnancy outcomes: a case–control study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhep.2005.05.023" "Revista" => array:7 [ "tituloSerie" => "J Hepatol" "fecha" => "2005" "volumen" => "43" "numero" => "5" "paginaInicial" => "771" "paginaFinal" => "775" "link" => array:1 [ …1] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0023" "etiqueta" => "[23]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Exacerbation of chronic hepatitis B infection after delivery" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "J Viral Hepat" "fecha" => "2007" "volumen" => "0" "numero" => "0" ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0024" "etiqueta" => "[24]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical course of 161 untreated and tenofovir-treated chronic hepatitis B pregnant patients in a low hepatitis B virus endemic region" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/jvh.12436" "Revista" => array:7 [ "tituloSerie" => "J Viral Hepat" "fecha" => "2016" "volumen" => "23" "numero" => "1" "paginaInicial" => "15" "paginaFinal" => "22" "link" => array:1 [ …1] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0025" "etiqueta" => "[25]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Serum AlanineAminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ajg.2016.296" "Revista" => array:7 [ "tituloSerie" => "Am J Gastroenterol" "fecha" => "2016" "volumen" => "111" "numero" => "10" "paginaInicial" => "1410" "paginaFinal" => "1415" "link" => array:1 [ …1] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0026" "etiqueta" => "[26]" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Terrault N.A., Bzowej N.H., Chang K.-.M., Hwang J.P., Jonas M.M., Murad M.H. AASLD guidelines for treatment of chronic hepatitis B: hepatology, Month 2015. Hepatology. 2016 Jan;63(1):261–83." ] ] ] 26 => array:3 [ "identificador" => "bib0027" "etiqueta" => "[27]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep.29800" "Revista" => array:7 [ "tituloSerie" => "Hepatology" "fecha" => "2018" "volumen" => "67" "numero" => "4" "paginaInicial" => "1560" "paginaFinal" => "1599" "link" => array:1 [ …1] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0028" "etiqueta" => "[28]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/bmj.38719.435833.7C" "Revista" => array:7 [ "tituloSerie" => "BMJ" "fecha" => "2006" "volumen" => "332" "numero" => "7537" "paginaInicial" => "328" "paginaFinal" => "336" "link" => array:1 [ …1] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0029" "etiqueta" => "[29]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mechanisms and Prevention of Vertical Transmission in Chronic Viral Hepatitis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.14218/JCTH.2016.00067" "Revista" => array:7 [ "tituloSerie" => "J Clin Transl Hepatol" "fecha" => "2017 Jun 28" "volumen" => "5" "numero" => "2" "paginaInicial" => "119" "paginaFinal" => "129" "link" => array:1 [ …1] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0030" "etiqueta" => "[30]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of pregnancy on pre-existing liver disease: chronic viral hepatitis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Ann Hepatol" "fecha" => "2006" "volumen" => "5" "numero" => "3" "paginaInicial" => "190" "paginaFinal" => "197" "link" => array:1 [ …1] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0031" "etiqueta" => "[31]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of carrier state" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/infdis/151.4.599" "Revista" => array:6 [ "tituloSerie" => "J Infect Dis" "fecha" => "1981" "volumen" => "151" "paginaInicial" => "599" "paginaFinal" => "603" "link" => array:1 [ …1] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0032" "etiqueta" => "[32]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/apt.12726" "Revista" => array:7 [ "tituloSerie" => "Aliment Pharmacol Ther" "fecha" => "2014" "volumen" => "39" "numero" => "10" "paginaInicial" => "1225" "paginaFinal" => "1234" "link" => array:1 [ …1] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0033" "etiqueta" => "[33]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Caesarean Section to Prevent Transmission of Hepatitis B: a Meta-Analysis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1155/2014/350179" "Revista" => array:7 [ "tituloSerie" => "Can J Gastroenterol Hepatol" "fecha" => "2014" "volumen" => "28" "numero" => "8" "paginaInicial" => "439" "paginaFinal" => "444" "link" => array:1 [ …1] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0034" "etiqueta" => "[34]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "#38: hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ajog.2015.09.100" "Revista" => array:7 [ "tituloSerie" => "Am J Obstet Gynecol" "fecha" => "2016" "volumen" => "214" "numero" => "1" "paginaInicial" => "6" "paginaFinal" => "14" "link" => array:1 [ …1] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0035" "etiqueta" => "[35]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/s0029-7844(02)02000-8" "Revista" => array:8 [ "tituloSerie" => "Obstet Gynecol" "fecha" => "2002" "volumen" => "99" "numero" => "6" "paginaInicial" => "1049" "paginaFinal" => "1052" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0036" "etiqueta" => "[36]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Hepatol" "fecha" => "2018" "volumen" => "68" "numero" => "1" "paginaInicial" => "33" "paginaFinal" => "41" ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0037" "etiqueta" => "[37]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Viral hepatitis and pregnancy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/s41575-020-00361-w" "Revista" => array:7 [ "tituloSerie" => "Nat Rev Gastroenterol Hepatol" "fecha" => "2021" "volumen" => "18" "numero" => "2" "paginaInicial" => "117" "paginaFinal" => "130" "link" => array:1 [ …1] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0038" "etiqueta" => "[38]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "In vitro fertilization for women infected by hepatitis C virus: a matched case-control study and a systematic literature review" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10815-017-0892-8" "Revista" => array:7 [ "tituloSerie" => "J Assist Reprod Genet" "fecha" => "2017" "volumen" => "34" "numero" => "5" "paginaInicial" => "587" "paginaFinal" => "597" "link" => array:1 [ …1] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0039" "etiqueta" => "[39]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Maternal HCV infection is associated with intrauterine fetal growth disturbance: a meta-analysis of observational studies" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MD.0000000000004777" "Revista" => array:6 [ "tituloSerie" => "Medicine" "fecha" => "2016 Aug" "volumen" => "95" "numero" => "35" "paginaInicial" => "e4777" "link" => array:1 [ …1] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0040" "etiqueta" => "[40]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Obstetrical and Neonatal Outcomes Among Women Infected With Hepatitis C and Their Infants" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S1701-2163(15)30480-1" "Revista" => array:7 [ "tituloSerie" => "J Obstet Gynaecol Can" "fecha" => "2014" "volumen" => "36" "numero" => "9" "paginaInicial" => "785" "paginaFinal" => "794" "link" => array:1 [ …1] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0041" "etiqueta" => "[41]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Increased Hepatitis C Virus (HCV) Detection in Women of Childbearing Age and Potential Risk for Vertical Transmission — United States and Kentucky, 2011–2014" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.15585/mmwr.mm6528a2" "Revista" => array:7 [ "tituloSerie" => "MMWR Morb Mortal Wkly Rep" "fecha" => "2016" "volumen" => "65" "numero" => "28" "paginaInicial" => "705" "paginaFinal" => "710" "link" => array:1 [ …1] ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0042" "etiqueta" => "[42]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hepatitis C in Pregnancy: a Unique Opportunity to Improve the Hepatitis C Cascade of Care" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep4.1282" "Revista" => array:7 [ "tituloSerie" => "Hepatology Communications. Hepatol Commun." "fecha" => "2019" "volumen" => "3" "numero" => "1" "paginaInicial" => "20" "paginaFinal" => "28" "link" => array:1 [ …1] ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0043" "etiqueta" => "[43]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Vertical Transmission of Hepatitis C Virus: systematic Review and Meta-analysis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/cid/ciu447" "Revista" => array:7 [ "tituloSerie" => "Clin Infect Dis" "fecha" => "2014" "volumen" => "59" "numero" => "6" "paginaInicial" => "765" "paginaFinal" => "773" "link" => array:1 [ …1] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0044" "etiqueta" => "[44]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection" "autores" => array:1 [ 0 => array:3 [ …3] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/cid/ciy585" "Revista" => array:7 [ "tituloSerie" => "Clin Infect Dis" "fecha" => "2018" "volumen" => "67" "numero" => "10" "paginaInicial" => "1477" "paginaFinal" => "1492" "link" => array:1 [ …1] ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0045" "etiqueta" => "[45]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "When does mother to child transmission of hepatitis C virus occur?" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Dis Child - Fetal Neonatal editor" "fecha" => "2005" "volumen" => "90" "numero" => "2" "paginaInicial" => "F156" "paginaFinal" => "F160" ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0046" "etiqueta" => "[46]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hepatitis C in pregnancy: screening, treatment, and management" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ajog.2017.07.039" "Revista" => array:7 [ "tituloSerie" => "Am J Obstet Gynecol" "fecha" => "2017" "volumen" => "217" "numero" => "5" "paginaInicial" => "B2" "paginaFinal" => "12" "link" => array:1 [ …1] ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0047" "etiqueta" => "[47]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reducing Risk for Mother-to-Infant Transmission of Hepatitis C Virus: a Systematic Review for the U.S. Preventive Services Task Force" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.7326/0003-4819-158-2-201301150-00575" "Revista" => array:6 [ "tituloSerie" => "Ann Intern Med" "fecha" => "2013" "volumen" => "158" "numero" => "2" "paginaInicial" => "109" "link" => array:1 [ …1] ] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib0048" "etiqueta" => "[48]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/liv.12902" "Revista" => array:7 [ "tituloSerie" => "Liver Int" "fecha" => "2016" "volumen" => "36" "numero" => "2" "paginaInicial" => "268" "paginaFinal" => "274" "link" => array:1 [ …1] ] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib0049" "etiqueta" => "[49]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mediterranean-style diet in pregnant women with metabolic risk factors (ESTEEM): a pragmatic multicentre randomised trial. Persson LÅ, editor" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "PLOS Med" "fecha" => "2019" "volumen" => "16" "numero" => "7" ] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib0050" "etiqueta" => "[50]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A protective effect of breastfeeding on the progression of non-alcoholic fatty liver disease" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/adc.2009.159566" "Revista" => array:7 [ "tituloSerie" => "Arch Dis Child" "fecha" => "2009" "volumen" => "94" "numero" => "10" "paginaInicial" => "801" "paginaFinal" => "805" "link" => array:1 [ …1] ] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib0051" "etiqueta" => "[51]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Outcomes of pregnancy in women with autoimmune hepatitis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaut.2011.12.002" "Revista" => array:7 [ "tituloSerie" => "J Autoimmun" "fecha" => "2012" "volumen" => "38" "numero" => "2–3" "paginaInicial" => "J239" "paginaFinal" => "J244" "link" => array:1 [ …1] ] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib0052" "etiqueta" => "[52]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Autoimmune hepatitis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhep.2015.06.030" "Revista" => array:7 [ "tituloSerie" => "J Hepatol" "fecha" => "2015" "volumen" => "63" "numero" => "4" "paginaInicial" => "971" "paginaFinal" => "1004" "link" => array:1 [ …1] ] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib0053" "etiqueta" => "[53]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep.31065" "Revista" => array:7 [ "tituloSerie" => "Hepatology" "fecha" => "2020" "volumen" => "72" "numero" => "2" "paginaInicial" => "671" "paginaFinal" => "722" "link" => array:1 [ …1] ] ] ] ] ] ] 53 => array:3 [ "identificador" => "bib0054" "etiqueta" => "[54]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ajg.2012.430" "Revista" => array:7 [ "tituloSerie" => "Am J Gastroenterol" "fecha" => "2013" "volumen" => "108" "numero" => "3" "paginaInicial" => "433" "paginaFinal" => "440" "link" => array:1 [ …1] ] ] ] ] ] ] 54 => array:3 [ "identificador" => "bib0055" "etiqueta" => "[55]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cgh.2017.02.041" "Revista" => array:7 [ "tituloSerie" => "Clin Gastroenterol Hepatol" "fecha" => "2017" "volumen" => "15" "numero" => "8" "paginaInicial" => "1232" "paginaFinal" => "1241" "link" => array:1 [ …1] ] ] ] ] ] ] 55 => array:3 [ "identificador" => "bib0056" "etiqueta" => "[56]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systematic Review and Meta-analysis on the Effects of Thiopurines on Birth Outcomes from Female and Male Patients with Inflammatory Bowel Disease" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/ibd.22948" "Revista" => array:7 [ "tituloSerie" => "Inflamm Bowel Dis" "fecha" => "2013" "volumen" => "19" "numero" => "1" "paginaInicial" => "15" "paginaFinal" => "22" "link" => array:1 [ …1] ] ] ] ] ] ] 56 => array:3 [ "identificador" => "bib0057" "etiqueta" => "[57]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancies in liver and kidney transplant recipients: a review of the current literature and recommendation" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.bpobgyn.2014.07.021" "Revista" => array:8 [ "tituloSerie" => "Best Pract Res Clin Obstet Gynaecol" "fecha" => "2014" "volumen" => "28" "numero" => "8" "paginaInicial" => "1123" "paginaFinal" => "1136" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 57 => array:3 [ "identificador" => "bib0058" "etiqueta" => "[58]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/gutjnl-2012-303615" "Revista" => array:7 [ "tituloSerie" => "Gut" "fecha" => "2014" "volumen" => "63" "numero" => "3" "paginaInicial" => "451" "paginaFinal" => "457" "link" => array:1 [ …1] ] ] ] ] ] ] 58 => array:3 [ "identificador" => "bib0059" "etiqueta" => "[59]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Corticosteroid use and risk of orofacial clefts: corticosteroid Use and Orofacial Clefts Risk" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Birt Defects Res A Clin Mol Teratol" "fecha" => "2014" "volumen" => "100" "numero" => "6" "paginaInicial" => "499" "paginaFinal" => "506" ] ] ] ] ] ] 59 => array:3 [ "identificador" => "bib0060" "etiqueta" => "[60]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Corticosteroid use during pregnancy and risk of orofacial clefts" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Can Med Assoc J" "fecha" => "2011" "volumen" => "183" "numero" => "7" "paginaInicial" => "796" "paginaFinal" => "804" ] ] ] ] ] ] 60 => array:3 [ "identificador" => "bib0061" "etiqueta" => "[61]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Gastroenterology" "fecha" => "2016" "volumen" => "150" "numero" => "3" ] ] ] ] ] ] 61 => array:3 [ "identificador" => "bib0062" "etiqueta" => "[62]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/01443615.2012.716106" "Revista" => array:7 [ "tituloSerie" => "J Obstet Gynaecol" "fecha" => "2013" "volumen" => "33" "numero" => "1" "paginaInicial" => "1" "paginaFinal" => "8" "link" => array:1 [ …1] ] ] ] ] ] ] 62 => array:3 [ "identificador" => "bib0063" "etiqueta" => "[63]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy outcomes following single and repeat liver transplantation: an international 2-center cohort" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/lt.25071" "Revista" => array:7 [ "tituloSerie" => "Liver Transpl" "fecha" => "2018" "volumen" => "24" "numero" => "6" "paginaInicial" => "769" "paginaFinal" => "778" "link" => array:1 [ …1] ] ] ] ] ] ] 63 => array:3 [ "identificador" => "bib0064" "etiqueta" => "[64]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systematic review with meta-analysis: mycophenolate mofetil as a second-line therapy for autoimmune hepatitis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/apt.15157" "Revista" => array:7 [ "tituloSerie" => "Aliment Pharmacol Ther" "fecha" => "2019" "volumen" => "49" "numero" => "7" "paginaInicial" => "830" "paginaFinal" => "839" "link" => array:1 [ …1] ] ] ] ] ] ] 64 => array:3 [ "identificador" => "bib0065" "etiqueta" => "[65]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The safety of mycophenolate mofetil in pregnancy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1517/14740338.7.3.219" "Revista" => array:8 [ "tituloSerie" => "Expert Opin Drug Saf" "fecha" => "2008" "volumen" => "7" "numero" => "3" "paginaInicial" => "219" "paginaFinal" => "222" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 65 => array:3 [ "identificador" => "bib0066" "etiqueta" => "[66]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Gastroenterology" "fecha" => "2013" "volumen" => "144" "numero" => "3" "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 66 => array:3 [ "identificador" => "bib0067" "etiqueta" => "[67]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "PREGNANCY IN PATIENTS WITH HEPATIC CIRRHOSIS" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "The Lancet" "fecha" => "1968" "volumen" => "292" "numero" => "7576" "paginaInicial" => "995" "paginaFinal" => "999" ] ] ] ] ] ] 67 => array:3 [ "identificador" => "bib0068" "etiqueta" => "[68]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Good Maternal and Fetal Outcomes for Pregnant Women With Primary Biliary Cirrhosis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cgh.2013.11.030" "Revista" => array:7 [ "tituloSerie" => "Clin Gastroenterol Hepatol" "fecha" => "2014" "volumen" => "12" "numero" => "7" "paginaInicial" => "1179" "paginaFinal" => "1185" "link" => array:1 [ …1] ] ] ] ] ] ] 68 => array:3 [ "identificador" => "bib0069" "etiqueta" => "[69]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy in women with primary biliary cirrhosis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.autrev.2014.05.008" "Revista" => array:7 [ "tituloSerie" => "Autoimmun Rev" "fecha" => "2014" "volumen" => "13" "numero" => "9" "paginaInicial" => "931" "paginaFinal" => "935" "link" => array:1 [ …1] ] ] ] ] ] ] 69 => array:3 [ "identificador" => "bib0070" "etiqueta" => "[70]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy and Primary Biliary Cirrhosis: a Case-Control Study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s12016-014-8433-z" "Revista" => array:8 [ "tituloSerie" => "Clin Rev Allergy Immunol" "fecha" => "2015" "volumen" => "48" "numero" => "2–3" "paginaInicial" => "236" "paginaFinal" => "242" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 70 => array:3 [ "identificador" => "bib0071" "etiqueta" => "[71]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy in primary sclerosing cholangitis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/gut.2010.228924" "Revista" => array:7 [ "tituloSerie" => "Gut" "fecha" => "2011" "volumen" => "60" "numero" => "8" "paginaInicial" => "1117" "paginaFinal" => "1121" "link" => array:1 [ …1] ] ] ] ] ] ] 71 => array:3 [ "identificador" => "bib0072" "etiqueta" => "[72]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A Population-based Cohort Study of Pregnancy Outcomes Among Women With Primary Sclerosing Cholangitis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cgh.2013.07.011" "Revista" => array:7 [ "tituloSerie" => "Clin Gastroenterol Hepatol" "fecha" => "2014" "volumen" => "12" "numero" => "1" "paginaInicial" => "95" "paginaFinal" => "100" "link" => array:1 [ …1] ] ] ] ] ] ] 72 => array:3 [ "identificador" => "bib0073" "etiqueta" => "[73]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy outcomes in women with primary biliary cholangitis and primary sclerosing cholangitis: a retrospective cohort study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BJOG Int J Obstet Gynaecol" "fecha" => "2020" "volumen" => "127" "numero" => "7" "paginaInicial" => "876" "paginaFinal" => "884" ] ] ] ] ] ] 73 => array:3 [ "identificador" => "bib0074" "etiqueta" => "[74]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Preterm birth time trends in Europe: a study of 19 countries" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BJOG Int J Obstet Gynaecol" "fecha" => "2013" "volumen" => "120" "numero" => "11" "paginaInicial" => "1356" "paginaFinal" => "1365" ] ] ] ] ] ] 74 => array:3 [ "identificador" => "bib0075" "etiqueta" => "[75]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy of Ursodeoxycholic Acid in Treating Intrahepatic Cholestasis of Pregnancy: a Meta-analysis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.gastro.2012.08.004" "Revista" => array:7 [ "tituloSerie" => "Gastroenterology" "fecha" => "2012" "volumen" => "143" "numero" => "6" "paginaInicial" => "1492" "paginaFinal" => "1501" "link" => array:1 [ …1] ] ] ] ] ] ] 75 => array:3 [ "identificador" => "bib0076" "etiqueta" => "[76]" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Lindor K.D., Bowlus C.L., Boyer J., Levy C., Mayo M., Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018 Nov 6;hep.30145." ] ] ] 76 => array:3 [ "identificador" => "bib0077" "etiqueta" => "[77]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy after liver transplantation" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.bpobgyn.2014.07.022" "Revista" => array:7 [ "tituloSerie" => "Best Pract Res Clin Obstet Gynaecol" "fecha" => "2014" "volumen" => "28" "numero" => "8" "paginaInicial" => "1137" "paginaFinal" => "1145" "link" => array:1 [ …1] ] ] ] ] ] ] 77 => array:3 [ "identificador" => "bib0078" "etiqueta" => "[78]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/lt.23416" "Revista" => array:7 [ "tituloSerie" => "Liver Transpl" "fecha" => "2012" "volumen" => "18" "numero" => "6" "paginaInicial" => "621" "paginaFinal" => "629" "link" => array:1 [ …1] ] ] ] ] ] ] 78 => array:3 [ "identificador" => "bib0079" "etiqueta" => "[79]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Outcomes of pregnancy following liver transplantation: the King's College Hospital experience: PREGNANCY AND LIVER TRANSPLANTATION" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/lt.24182" "Revista" => array:7 [ "tituloSerie" => "Liver Transpl" "fecha" => "2015" "volumen" => "21" "numero" => "9" "paginaInicial" => "1153" "paginaFinal" => "1159" "link" => array:1 [ …1] ] ] ] ] ] ] 79 => array:3 [ "identificador" => "bib0080" "etiqueta" => "[80]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy outcomes in liver transplant patients, a population-based study" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3109/14767058.2016.1173671" "Revista" => array:7 [ "tituloSerie" => "J Matern Fetal Neonatal Med" "fecha" => "2017" "volumen" => "30" "numero" => "3" "paginaInicial" => "261" "paginaFinal" => "266" "link" => array:1 [ …1] ] ] ] ] ] ] 80 => array:3 [ "identificador" => "bib0081" "etiqueta" => "[81]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy Outcomes After Liver Transplantation: a Systematic Review" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.transproceed.2019.01.014" "Revista" => array:7 [ "tituloSerie" => "Transplant Proc" "fecha" => "2019" "volumen" => "51" "numero" => "2" "paginaInicial" => "446" "paginaFinal" => "449" "link" => array:1 [ …1] ] ] ] ] ] ] 81 => array:3 [ "identificador" => "bib0082" "etiqueta" => "[82]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy outcomes in women with liver transplants: systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.hpb.2020.05.001" "Revista" => array:7 [ "tituloSerie" => "HPB" "fecha" => "2020" "volumen" => "22" "numero" => "8" "paginaInicial" => "1102" "paginaFinal" => "1111" "link" => array:1 [ …1] ] ] ] ] ] ] 82 => array:3 [ "identificador" => "bib0083" "etiqueta" => "[83]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Successful pregnancy outcomes following liver transplantation is predicted by renal function: lim et al" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/lt.25034" "Revista" => array:7 [ "tituloSerie" => "Liver Transpl" "fecha" => "2018" "volumen" => "24" "numero" => "5" "paginaInicial" => "606" "paginaFinal" => "615" "link" => array:1 [ …1] ] ] ] ] ] ] 83 => array:3 [ "identificador" => "bib0084" "etiqueta" => "[84]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Delivery Method in Patients After Liver or Kidney Transplantation" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.transproceed.2018.05.003" "Revista" => array:7 [ "tituloSerie" => "Transplant Proc" "fecha" => "2018" "volumen" => "50" "numero" => "7" "paginaInicial" => "2150" "paginaFinal" => "2153" "link" => array:1 [ …1] ] ] ] ] ] ] 84 => array:3 [ "identificador" => "bib0085" "etiqueta" => "[85]" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Jain A.B., Reyes, J., Marcos, A., Mazariegos G., Eghtesad B., Fontes P.A., Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center’s experience update at 13 years1, Transplantation: September 15, 2003 - Volume 76 - Issue 5 - p 827-832" ] ] ] 85 => array:3 [ "identificador" => "bib0086" "etiqueta" => "[86]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "Clin Transpl" "fecha" => "2009" "paginaInicial" => "103" "paginaFinal" => "122" ] ] ] ] ] ] 86 => array:3 [ "identificador" => "bib0087" "etiqueta" => "[87]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation: management of the Successful Adult Liver Transplant" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/lt.23566" "Revista" => array:7 [ "tituloSerie" => "Liver Transpl" "fecha" => "2013" "volumen" => "19" "numero" => "1" "paginaInicial" => "3" "paginaFinal" => "26" "link" => array:1 [ …1] ] ] ] ] ] ] 87 => array:3 [ "identificador" => "bib0088" "etiqueta" => "[88]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/lt.20810" "Revista" => array:7 [ "tituloSerie" => "Liver Transpl" "fecha" => "2006" "volumen" => "12" "numero" => "7" "paginaInicial" => "1138" "paginaFinal" => "1143" "link" => array:1 [ …1] ] ] ] ] ] ] 88 => array:3 [ "identificador" => "bib0089" "etiqueta" => "[89]" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Cyclosporine. In: drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): national Library of Medicine (US); 2006 [cited 2020 Jul 28]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK501683/" ] ] ] 89 => array:3 [ "identificador" => "bib0090" "etiqueta" => "[90]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Time to Conversion to an Everolimus-Based Regimen: renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/lt.25879" "Revista" => array:8 [ "tituloSerie" => "Liver Transpl" "fecha" => "2020" "volumen" => "26" "numero" => "11" "paginaInicial" => "1465" "paginaFinal" => "1476" "link" => array:1 [ …1] "itemHostRev" => array:3 [ …3] ] ] ] ] ] ] 90 => array:3 [ "identificador" => "bib0091" "etiqueta" => "[91]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Which drugs are contraindicated during breastfeeding? Practice guidelines" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Can Fam Physician Med Fam Can" "fecha" => "2000" "volumen" => "46" "paginaInicial" => "1753" "paginaFinal" => "1757" ] ] ] ] ] ] 91 => array:3 [ "identificador" => "bib0092" "etiqueta" => "[92]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Tacrolimus placental transfer at delivery and neonatal exposure through breast milk: tacrolimus placental transfer and neonatal exposure" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/bcp.12122" "Revista" => array:7 [ "tituloSerie" => "Br J Clin Pharmacol" "fecha" => "2013" "volumen" => "76" "numero" => "6" "paginaInicial" => "988" "paginaFinal" => "996" "link" => array:1 [ …1] ] ] ] ] ] ] 92 => array:3 [ "identificador" => "bib0093" "etiqueta" => "[93]" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Gouraud A., Bernard N., Millaret A., Bruel M., Paret N., Descotes J., Follow-Up of Tacrolimus Breastfed Babies: Transplant J. 2012 Sep;94(6):e38–40." ] ] ] 93 => array:3 [ "identificador" => "bib0094" "etiqueta" => "[94]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Azathioprine treatment during lactation" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2036.2008.03843.x" "Revista" => array:7 [ "tituloSerie" => "Aliment Pharmacol Ther" "fecha" => "2008" "volumen" => "28" "numero" => "10" "paginaInicial" => "1209" "paginaFinal" => "1213" "link" => array:1 [ …1] ] ] ] ] ] ] 94 => array:3 [ "identificador" => "bib0095" "etiqueta" => "[95]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Azathioprine and breastfeeding-is it safe?" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "BJOG Int J Obstet Gynaecol" "fecha" => "2007" "volumen" => "114" "numero" => "4" "paginaInicial" => "498" "paginaFinal" => "501" ] ] ] ] ] ] 95 => array:3 [ "identificador" => "bib0096" "etiqueta" => "[96]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Levels of the beta-blockers atenolol and propranolol in the breast milk of women treated for hypertension in pregnancy" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/bdd.2510040310" "Revista" => array:7 [ "tituloSerie" => "Biopharm Drug Dispos" "fecha" => "1983" "volumen" => "4" "numero" => "3" "paginaInicial" => "299" "paginaFinal" => "301" "link" => array:1 [ …1] ] ] ] ] ] ] 96 => array:3 [ "identificador" => "bib0097" "etiqueta" => "[97]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "EXCRETION OF ANTIHYPERTENSIVE MEDICATION INTO HUMAN BREAST MILK: a SYSTEMATIC REVIEW" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1081/PRG-120002912" "Revista" => array:7 [ "tituloSerie" => "Hypertens Pregnancy" "fecha" => "2002" "volumen" => "21" "numero" => "1" "paginaInicial" => "85" "paginaFinal" => "95" "link" => array:1 [ …1] ] ] ] ] ] ] 97 => array:3 [ "identificador" => "bib0098" "etiqueta" => "[98]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Concentrations of Tenofovir and Emtricitabine in Breast Milk of HIV-1-Infected Women in Abidjan, Côte d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1128/AAC.00514-10" "Revista" => array:7 [ "tituloSerie" => "Antimicrob Agents Chemother" "fecha" => "2011" "volumen" => "55" "numero" => "3" "paginaInicial" => "1315" "paginaFinal" => "1317" "link" => array:1 [ …1] ] ] ] ] ] ] 98 => array:3 [ "identificador" => "bib0099" "etiqueta" => "[99]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother–infant pairs" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/jac/dkx507" "Revista" => array:7 [ "tituloSerie" => "J Antimicrob Chemother" "fecha" => "2018" "volumen" => "73" "numero" => "4" "paginaInicial" => "1013" "paginaFinal" => "1019" "link" => array:1 [ …1] ] ] ] ] ] ] 99 => array:3 [ "identificador" => "bib0100" "etiqueta" => "[100]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prednisone Pharmacokinetics During Pregnancy and Lactation" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/jcph.1122" "Revista" => array:7 [ "tituloSerie" => "J Clin Pharmacol" "fecha" => "2018" "volumen" => "58" "numero" => "9" "paginaInicial" => "1223" "paginaFinal" => "1232" "link" => array:1 [ …1] ] ] ] ] ] ] 100 => array:3 [ "identificador" => "bib0101" "etiqueta" => "[101]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/s0002-9378(11)90771-6" "Revista" => array:7 [ "tituloSerie" => "Am J Obstet Gynecol" "fecha" => "1993" "volumen" => "168" "numero" => "5" "paginaInicial" => "1393" "paginaFinal" => "1399" "link" => array:1 [ …1] ] ] ] ] ] ] 101 => array:3 [ "identificador" => "bib0102" "etiqueta" => "[102]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "PREGNANCY OUTCOME AFTER CYCLOSPORINE THERAPY DURING PREGNANCY: a META-ANALYSIS1" "autores" => array:1 [ 0 => array:2 [ …2] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/00007890-200104270-00006" "Revista" => array:7 [ "tituloSerie" => "Transplantation" "fecha" => "2001" "volumen" => "71" "numero" => "8" "paginaInicial" => "1051" …2 ] ] ] ] ] ] 102 => array:3 [ "identificador" => "bib0103" "etiqueta" => "[103]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/s0168-8278(98)80255-9" "Revista" => array:7 [ …7] ] ] ] ] ] 103 => array:3 [ "identificador" => "bib0104" "etiqueta" => "[104]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.dld.2010.06.002" "Revista" => array:7 [ …7] ] ] ] ] ] 104 => array:3 [ "identificador" => "bib0105" "etiqueta" => "[105]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Breastfeeding and Tacrolimus: serial Monitoring in Breast-Fed and Bottle-Fed Infants" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2215/CJN.06400612" "Revista" => array:7 [ …7] ] ] ] ] ] 105 => array:3 [ "identificador" => "bib0106" "etiqueta" => "[106]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cyclosporine excretion into breast milk" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.TP.0000066352.86763.D0" "Revista" => array:8 [ …8] ] ] ] ] ] 106 => array:3 [ "identificador" => "bib0107" "etiqueta" => "[107]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Update on the Teratogenicity of Maternal Mycophenolate Mofetil" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] 107 => array:3 [ "identificador" => "bib0108" "etiqueta" => "[108]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Transfer of Everolimus into Colostrum of a Kidney Transplant Mother" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.12659/aot.907944" "Revista" => array:6 [ …6] ] ] ] ] ] 108 => array:3 [ "identificador" => "bib0109" "etiqueta" => "[109]" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Transplant Pregnancy Registry International, a Division of Gift of Life Institute, 2020, Philadelphia, PA. [cited 2020 May 9]; Available from: https://www.transplantpregnancyregistry.org." ] ] ] 109 => array:3 [ "identificador" => "bib0110" "etiqueta" => "[110]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Successful Maternal and Fetal Outcome in a Kidney Transplant Patient with Everolimus Exposure Throughout Pregnancy: a Case Report" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.transproceed.2013.09.029" "Revista" => array:7 [ …7] ] ] ] ] ] 110 => array:3 [ "identificador" => "bib0111" "etiqueta" => "[111]" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "First Report of a Successful Pregnancy in an Everolimus-Treated Heart-Transplanted Patient: neonatal Disappearance of Immunosuppressive Drugs" "autores" => array:1 [ …1] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ …6] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack622264" "titulo" => "Funding" "texto" => "<p id="para0057" class="elsevierStylePara elsevierViewall">HDT receives funding from <span class="elsevierStyleGrantSponsor" id="gs0001">educational T32</span> (<span class="elsevierStyleGrantNumber" refid="gs0001">5T32DK007760–20</span>). There are no other relevant funding sources.</p>" "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/000000260000000C/v5_202208200714/S1665268121002568/v5_202208200714/en/main.assets" "Apartado" => array:4 [ "identificador" => "77774" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Concise reviews" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/16652681/000000260000000C/v5_202208200714/S1665268121002568/v5_202208200714/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268121002568?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 9 | 0 | 9 |
2024 October | 61 | 7 | 68 |
2024 September | 86 | 8 | 94 |
2024 August | 70 | 12 | 82 |
2024 July | 67 | 12 | 79 |
2024 June | 75 | 8 | 83 |
2024 May | 61 | 3 | 64 |
2024 April | 68 | 8 | 76 |
2024 March | 99 | 18 | 117 |
2024 February | 72 | 10 | 82 |
2024 January | 97 | 14 | 111 |
2023 December | 66 | 11 | 77 |
2023 November | 83 | 17 | 100 |
2023 October | 103 | 18 | 121 |
2023 September | 40 | 6 | 46 |
2023 August | 55 | 7 | 62 |
2023 July | 50 | 9 | 59 |
2023 June | 47 | 14 | 61 |
2023 May | 38 | 3 | 41 |
2023 April | 48 | 12 | 60 |
2023 March | 40 | 98 | 138 |
2023 February | 21 | 5 | 26 |
2023 January | 15 | 10 | 25 |
2022 December | 26 | 10 | 36 |
2022 November | 25 | 10 | 35 |
2022 October | 34 | 10 | 44 |
2022 September | 29 | 15 | 44 |
2022 August | 29 | 7 | 36 |
2022 July | 19 | 11 | 30 |
2022 June | 32 | 17 | 49 |
2022 May | 10 | 10 | 20 |
2022 April | 45 | 15 | 60 |
2022 March | 57 | 15 | 72 |
2022 February | 34 | 14 | 48 |
2022 January | 63 | 40 | 103 |
2021 December | 31 | 29 | 60 |
2021 November | 12 | 17 | 29 |
2021 October | 6 | 0 | 6 |